Comparative	O
analysis	O
identifies	O
conserved	O
tumor	B-DNA
necrosis	I-DNA
factor	I-DNA
receptor-associated	I-DNA
factor	I-DNA
3	I-DNA
binding	I-DNA
sites	I-DNA
in	O
the	O
human	B-DNA
and	I-DNA
simian	I-DNA
Epstein-Barr	I-DNA
virus	I-DNA
oncogene	I-DNA
LMP1	I-DNA
.	O

Nonhuman	O
primates	O
are	O
naturally	O
infected	O
with	O
a	O
B-lymphotropic	O
herpesvirus	O
closely	O
related	O
to	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
.	O

These	O
simian	O
EBV	O
share	O
considerable	O
genetic	O
,	O
biologic	O
,	O
and	O
epidemiologic	O
features	O
with	O
human	O
EBV	O
,	O
including	O
virus-induced	O
tumorigenesis	O
.	O

However	O
,	O
latent	O
,	O
transformation-associated	O
viral	O
genes	O
demonstrate	O
marked	O
sequence	O
divergence	O
among	O
species	O
despite	O
the	O
conserved	O
functions	O
.	O

We	O
have	O
cloned	O
the	O
latent	B-protein
membrane	I-protein
protein	I-protein
1	I-protein
(	I-protein
LMP1	I-protein
)	I-protein
homologs	I-protein
from	O
the	O
simian	O
EBV	O
naturally	O
infecting	O
baboons	O
(	O
cercopithicine	O
herpesvirus	O
12	O
,	O
herpesvirus	O
papio	O
)	O
and	O
rhesus	O
monkeys	O
(	O
cercopithicine	O
herpesvirus	O
15	O
)	O
for	O
a	O
comparative	O
study	O
with	O
the	O
human	O
EBV	O
oncogene	O
.	O

The	O
transmembrane	O
domains	O
are	O
well	O
conserved	O
,	O
but	O
there	O
is	O
striking	O
sequence	O
divergence	O
of	O
the	O
carboxy-terminal	B-protein
cytoplasmic	I-protein
domain	I-protein
essential	O
for	O
B-cell	B-cell_type
immortalization	O
and	O
interaction	O
with	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
receptor	I-protein
signaling	O
pathway	O
.	O

Nevertheless	O
,	O
the	O
simian	B-protein
EBV	I-protein
LMP1s	I-protein
retain	O
most	O
functions	O
in	O
common	O
with	O
EBV	O
LMP1	B-protein
,	O
including	O
the	O
ability	O
to	O
induce	O
NF-	B-protein
(	I-protein
kappa	I-protein
)	I-protein
B	I-protein
activity	O
in	O
human	B-cell_type
cells	I-cell_type
,	O
to	O
bind	O
the	O
tumor	B-protein
necrosis	I-protein
factor-associated	I-protein
factor	I-protein
3	I-protein
(	O
TRAF3	B-protein
)	O
in	O
vitro	O
,	O
and	O
to	O
induce	O
expression	O
of	O
tumor	B-DNA
necrosis	I-DNA
factor-responsive	I-DNA
genes	I-DNA
,	O
such	O
as	O
ICAM1	B-DNA
,	O
in	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

Multiple	O
TRAF3	B-DNA
binding	I-DNA
sites	I-DNA
containing	O
a	O
PXQXT/S	B-DNA
core	I-DNA
sequence	I-DNA
can	O
be	O
identified	O
in	O
the	O
simian	B-protein
EBV	I-protein
LMP1s	I-protein
by	O
an	O
in	O
vitro	O
binding	O
assay	O
.	O

A	O
PXQXT/S-containing	B-DNA
sequence	I-DNA
is	O
also	O
present	O
in	O
the	O
cytoplasmic	B-protein
domain	I-protein
of	O
the	O
Hodgkin	O
's	O
disease	O
marker	O
,	O
CD30	B-protein
,	O
and	O
binds	O
TRAF3	B-protein
in	O
vitro	O
.	O

The	O
last	B-protein
13	I-protein
amino	I-protein
acids	I-protein
containing	O
a	O
PXQXT/S	B-DNA
sequence	I-DNA
are	O
highly	O
conserved	O
in	O
human	O
and	O
simian	O
EBV	O
LMP1	B-protein
but	O
do	O
not	O
bind	O
TRAF3	B-protein
,	O
suggesting	O
a	O
distinct	O
role	O
for	O
this	O
conserved	O
region	O
of	O
LMP1	B-protein
.	O

The	O
conserved	O
TRAF3	B-DNA
binding	I-DNA
sites	I-DNA
in	O
LMP1	B-protein
and	O
the	O
CD30	B-protein
Hodgkin	I-protein
's	I-protein
disease	I-protein
marker	I-protein
provides	O
further	O
evidence	O
that	O
a	O
TRAF3	B-protein
-mediated	O
signal	O
transduction	O
pathway	O
may	O
be	O
important	O
in	O
malignant	O
transformation	O
.	O

JOURNAL	NULL
OF	NULL
VIROLOGY	NULL
,	NULL
Nov.	NULL
1996	NULL
,	NULL
p.	NULL
7819-7826	NULL
0022-538X	NULL
,	NULL
/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
Â©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

11	NULL
Comparative	NULL
Analysis	NULL
Identifies	NULL
Conserved	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Receptor-Associated	NULL
Factor	NULL
3	NULL
Binding	NULL
Sites	NULL
in	NULL
the	NULL
Human	NULL
and	NULL
Simian	NULL
Epstein-Barr	NULL
Virus	NULL
Oncogene	NULL
LMP1	NULL
MICHAEL	NULL
FRANKEN	NULL
,	NULL
'	NULL
ODILE	NULL
DEVERGNE	NULL
,	NULL
*	NULL
``	NULL
MICHAEL	NULL
ROSENZWEIG	NULL
,	NULL
``	NULL
BETHANY	NULL
ANNIS	NULL
,	NULL
'	NULL
ELLIOTT	NULL
KIEFF	NULL
,	NULL
``	NULL
anp	NULL
FRED	NULL
WANG	NULL
'	NULL
!	NULL

*	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Brigham	NULL
&	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
}	NULL
and	NULL
Department	NULL
of	NULL
Microbiology	NULL
and	NULL
Molecular	NULL
Genetics	NULL
,	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
``	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
New	NULL
England	NULL
Regional	NULL
Primate	NULL
Research	NULL
Center	NULL
,	NULL
Southborough	NULL
,	NULL
Massachusetts	NULL
01772	NULL
``	NULL
Received	NULL
21	NULL
May	NULL
1996/Accepted	NULL
23	NULL
July	NULL
1996	NULL
Nonhuman	NULL
primates	NULL
are	NULL
naturally	NULL
infected	NULL
with	NULL
a	NULL
B-lymphotropic	NULL
herpesvirus	NULL
closely	NULL
related	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
.	NULL

These	NULL
simian	NULL
EBV	NULL
share	NULL
considerable	NULL
genetic	NULL
,	NULL
biologic	NULL
,	NULL
and	NULL
epidemiologic	NULL
features	NULL
with	NULL
human	NULL
EBV	NULL
,	NULL
including	NULL
virus-induced	NULL
tumorigenesis	NULL
.	NULL

However	NULL
,	NULL
latent	NULL
,	NULL
transformation-associated	NULL
viral	NULL
genes	NULL
demonstrate	NULL
marked	NULL
sequence	NULL
divergence	NULL
among	NULL
species	NULL
despite	NULL
the	NULL
conserved	NULL
functions	NULL
.	NULL

We	NULL
have	NULL
cloned	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
homologs	NULL
from	NULL
the	NULL
simian	NULL
EBV	NULL
naturally	NULL
infecting	NULL
baboons	NULL
(	NULL
cercopithicine	NULL
herpesvirus	NULL
12	NULL
,	NULL
herpesvirus	NULL
papio	NULL
)	NULL
and	NULL
rhesus	NULL
monkeys	NULL
(	NULL
cercopithicine	NULL
herpesvirus	NULL
15	NULL
)	NULL
for	NULL
a	NULL
comparative	NULL
study	NULL
with	NULL
the	NULL
human	NULL
EBV	NULL
oncogene	NULL
.	NULL

The	NULL
transmembrane	NULL
domains	NULL
are	NULL
well	NULL
conserved	NULL
,	NULL
but	NULL
there	NULL
is	NULL
striking	NULL
sequence	NULL
divergence	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
essential	NULL
for	NULL
B-cell	NULL
immortalization	NULL
and	NULL
interaction	NULL
with	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
signaling	NULL
pathway	NULL
.	NULL

Nevertheless	NULL
,	NULL
the	NULL
simian	NULL
EBV	NULL
LMP1Is	NULL
retain	NULL
most	NULL
functions	NULL
in	NULL
common	NULL
with	NULL
EBV	NULL
LMP1	NULL
,	NULL
including	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
NF-KB	NULL
activity	NULL
in	NULL
human	NULL
cells	NULL
,	NULL
to	NULL
bind	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor-associated	NULL
factor	NULL
3	NULL
(	NULL
TRAF3	NULL
)	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
to	NULL
induce	NULL
expression	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-responsive	NULL
genes	NULL
,	NULL
such	NULL
as	NULL
ICAM1	NULL
,	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Multiple	NULL
TRAF3	NULL
binding	NULL
sites	NULL
containing	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
the	NULL
simian	NULL
EBV	NULL
LMP1s	NULL
by	NULL
an	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
.	NULL

A	NULL
PXQXT/S-containing	NULL
sequence	NULL
is	NULL
also	NULL
present	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
Hodgkin	NULL
's	NULL
disease	NULL
marker	NULL
,	NULL
CD30	NULL
,	NULL
and	NULL
binds	NULL
TRAF3	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
last	NULL
13	NULL
amino	NULL
acids	NULL
containing	NULL
a	NULL
PXQXT/S	NULL
sequence	NULL
are	NULL
highly	NULL
conserved	NULL
in	NULL
human	NULL
and	NULL
simian	NULL
EBV	NULL
LMP1	NULL
but	NULL
do	NULL
not	NULL
bind	NULL
TRAF3	NULL
,	NULL
suggesting	NULL
a	NULL
distinct	NULL
role	NULL
for	NULL
this	NULL
conserved	NULL
region	NULL
of	NULL
LMP1	NULL
.	NULL

The	NULL
conserved	NULL
TRAF3	NULL
binding	NULL
sites	NULL
in	NULL
LMP1	NULL
and	NULL
the	NULL
CD30	NULL
Hodgkin	NULL
's	NULL
disease	NULL
marker	NULL
provides	NULL
further	NULL
evidence	NULL
that	NULL
a	NULL
TRAF3-mediated	NULL
signal	NULL
transduction	NULL
pathway	NULL
may	NULL
be	NULL
important	NULL
in	NULL
malignant	NULL
trans-	NULL
formation	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
human	NULL
herpesvirus	NULL
which	NULL
infects	NULL
and	NULL
persists	NULL
asymptomatically	NULL
for	NULL
life	NULL
in	NULL
nearly	NULL
all	NULL
adults	NULL
.	NULL

In	NULL
vitro	NULL
,	NULL
EBV	NULL
infection	NULL
of	NULL
B	NULL
cells	NULL
results	NULL
in	NULL
perpetual	NULL
cell	NULL
proliferation	NULL
,	NULL
and	NULL
in	NULL
vivo	NULL
,	NULL
EBV	NULL
contributes	NULL
to	NULL
uncontrolled	NULL
cell	NULL
proliferation	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
,	NULL
B-cell	NULL
lymphomas	NULL
in	NULL
immunodeficient	NULL
patients	NULL
,	NULL
nasopharyngeal	NULL
carcinomas	NULL
,	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
40	NULL
)	NULL
.	NULL

Old	NULL
World	NULL
primates	NULL
are	NULL
naturally	NULL
infected	NULL
with	NULL
simian	NULL
herpesviruses	NULL
,	NULL
referred	NULL
to	NULL
here	NULL
as	NULL
simian	NULL
EBV	NULL
,	NULL
which	NULL
share	NULL
many	NULL
molecular	NULL
and	NULL
biologic	NULL
features	NULL
with	NULL
human	NULL
EBV	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
1	NULL
and	NULL
9	NULL
)	NULL
.	NULL

Simian	NULL
EBV	NULL
can	NULL
immortalize	NULL
the	NULL
growth	NULL
of	NULL
primary	NULL
B	NULL
cells	NULL
in	NULL
vitro	NULL
(	NULL
11	NULL
)	NULL
,	NULL
and	NULL
the	NULL
viral	NULL
genomes	NULL
are	NULL
colinear	NULL
,	NULL
with	NULL
approximately	NULL
40	NULL
%	NULL
nucleotide	NULL
homology	NULL
overall	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Human	NULL
and	NULL
simian	NULL
serum	NULL
antibodies	NULL
cross-react	NULL
with	NULL
lytic	NULL
cycle	NULL
antigens	NULL
from	NULL
both	NULL
human	NULL
and	NULL
simian	NULL
EBV	NULL
,	NULL
and	NULL
serologic	NULL
studies	NULL
indicate	NULL
that	NULL
seropositivity	NULL
is	NULL
as	NULL
ubiquitous	NULL
in	NULL
adult	NULL
monkeys	NULL
as	NULL
in	NULL
humans	NULL
(	NULL
5	NULL
,	NULL
7	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Immunocom-petent	NULL
nonhuman	NULL
primates	NULL
are	NULL
persistently	NULL
infected	NULL
with	NULL
simian	NULL
EBV	NULL
(	NULL
25	NULL
,	NULL
38	NULL
)	NULL
,	NULL
and	NULL
simian	NULL
EBV-infected	NULL
B-cell	NULL
lymphomas	NULL
arise	NULL
in	NULL
animals	NULL
immunosuppressed	NULL
by	NULL
the	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
(	NULL
8	NULL
)	NULL
,	NULL
thereby	NULL
reproducing	NULL
both	NULL
the	NULL
latency	NULL
and	NULL
tumorigenicity	NULL
associated	NULL
with	NULL
EBV	NULL
infection	NULL
of	NULL
humans	NULL
.	NULL

There	NULL
is	NULL
considerable	NULL
conservation	NULL
of	NULL
lytic	NULL
genes	NULL
among	NULL
all	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Brigham	NULL
&	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
75	NULL
Francis	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
fredw	NULL
@	NULL
bustoff.bwh.harvard.edu	NULL
.	NULL

7819	NULL
herpesviruses	NULL
,	NULL
as	NULL
expected	NULL
from	NULL
the	NULL
common	NULL
viral	NULL
structure	NULL
and	NULL
replication	NULL
mechanisms	NULL
;	NULL
however	NULL
,	NULL
the	NULL
EBV	NULL
latent	NULL
genes	NULL
associated	NULL
with	NULL
B-cell	NULL
transformation	NULL
are	NULL
unique	NULL
to	NULL
the	NULL
B-lymphotropic	NULL
herpesviruses	NULL
.	NULL

One	NULL
might	NULL
predict	NULL
that	NULL
evolution	NULL
of	NULL
viruses	NULL
sharing	NULL
B-cell-immortalizing	NULL
properties	NULL
would	NULL
select	NULL
for	NULL
human	NULL
and	NULL
simian	NULL
EBV	NULL
latent	NULL
genes	NULL
with	NULL
similar	NULL
functions	NULL
through	NULL
their	NULL
interaction	NULL
with	NULL
cell	NULL
proteins	NULL
involved	NULL
in	NULL
growth	NULL
regulation	NULL
.	NULL

These	NULL
phylogenetically	NULL
``	NULL
newer	NULL
``	NULL
viral	NULL
genes	NULL
may	NULL
not	NULL
have	NULL
the	NULL
same	NULL
degree	NULL
of	NULL
global	NULL
sequence	NULL
homology	NULL
as	NULL
the	NULL
``	NULL
older	NULL
``	NULL
lytic	NULL
genes	NULL
but	NULL
are	NULL
likely	NULL
to	NULL
share	NULL
the	NULL
essential	NULL
amino	NULL
acids	NULL
residues	NULL
necessary	NULL
for	NULL
interacting	NULL
with	NULL
conserved	NULL
cell	NULL
proteins	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
EBNA-2	NULL
and	NULL
LMP2A	NULL
homologs	NULL
in	NULL
the	NULL
baboon	NULL
EBV	NULL
(	NULL
cercopithicine	NULL
herpesvirus	NULL
12	NULL
,	NULL
herpesvirus	NULL
papio	NULL
)	NULL
show	NULL
striking	NULL
global	NULL
sequence	NULL
divergence	NULL
with	NULL
those	NULL
in	NULL
human	NULL
EBV	NULL
,	NULL
but	NULL
the	NULL
critical	NULL
amino	NULL
acid	NULL
residues	NULL
making	NULL
up	NULL
the	NULL
functional	NULL
domains	NULL
are	NULL
conserved	NULL
(	NULL
10	NULL
,	NULL
30	NULL
)	NULL
.	NULL

The	NULL
baboon	NULL
EBNA-2	NULL
retains	NULL
transcriptional	NULL
transactivating	NULL
function	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
by	NULL
preserving	NULL
a	NULL
critical	NULL
tryptophan	NULL
repeat	NULL
which	NULL
mediates	NULL
binding	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
RBP/Jk	NULL
(	NULL
29	NULL
)	NULL
,	NULL
and	NULL
the	NULL
baboon	NULL
LMP2A	NULL
retains	NULL
interaction	NULL
with	NULL
tyrosine	NULL
kinases	NULL
through	NULL
conserved	NULL
ITAM	NULL
motifs	NULL
despite	NULL
significant	NULL
global	NULL
sequence	NULL
differences	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Evolution	NULL
of	NULL
these	NULL
related	NULL
primate	NULL
viruses	NULL
has	NULL
resulted	NULL
in	NULL
naturally	NULL
occurring	NULL
variants	NULL
of	NULL
transformation-associated	NULL
viral	NULL
genes	NULL
which	NULL
can	NULL
provide	NULL
insight	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
viral	NULL
interaction	NULL
with	NULL
cell	NULL
proteins	NULL
.	NULL

The	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
since	NULL
it	NULL
is	NULL
essential	NULL
for	NULL
B-cell	NULL
immortalization	NULL
and	NULL
possesses	NULL
transforming	NULL
activity	NULL
in	NULL
rodent	NULL
fibroblast	NULL
assays	NULL
(	NULL
22	NULL
,	NULL
7820	NULL
FRANKEN	NULL
ET	NULL
AL	NULL
.	NULL

43	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
LMP1	NULL
in	NULL
malignant	NULL
transformation	NULL
is	NULL
underscored	NULL
by	NULL
the	NULL
frequent	NULL
detection	NULL
of	NULL
LMP1	NULL
expression	NULL
in	NULL
vivo	NULL
from	NULL
immunodeficiency-associated	NULL
B-cell	NULL
lymphomas	NULL
,	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
and	NULL
both	NULL
preneo-plastic	NULL
and	NULL
neoplastic	NULL
nasopharyngeal	NULL
lesions	NULL
(	NULL
16	NULL
,	NULL
36	NULL
,	NULL
48	NULL
)	NULL
.	NULL

The	NULL
mechanisms	NULL
by	NULL
which	NULL
this	NULL
integral	NULL
viral	NULL
membrane	NULL
protein	NULL
stimulates	NULL
cell	NULL
gene	NULL
expression	NULL
and	NULL
contributes	NULL
to	NULL
cell	NULL
proliferation	NULL
remain	NULL
to	NULL
be	NULL
delineated	NULL
,	NULL
but	NULL
transfection	NULL
studies	NULL
have	NULL
identified	NULL
a	NULL
number	NULL
of	NULL
targets	NULL
that	NULL
are	NULL
activated	NULL
by	NULL
LMP1	NULL
expression	NULL
,	NULL
including	NULL
B-cell	NULL
activation	NULL
antigens	NULL
,	NULL
cell	NULL
adhesion	NULL
molecules	NULL
,	NULL
vimentin	NULL
,	NULL
HLA	NULL
class	NULL
II	NULL
,	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
,	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
anti-apoptosis	NULL
genes	NULL
be/-2	NULL
and	NULL
A20	NULL
(	NULL
3	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
24	NULL
,	NULL
37	NULL
,	NULL
44	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Mosialos	NULL
et	NULL
al	NULL
.	NULL

have	NULL
recently	NULL
identified	NULL
a	NULL
novel	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor-associated	NULL
protein	NULL
,	NULL
TRAF3	NULL
,	NULL
which	NULL
binds	NULL
to	NULL
the	NULL
LMP1	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
important	NULL
for	NULL
LMP1	NULL
signal	NULL
transduction	NULL
(	NULL
34	NULL
)	NULL
.	NULL

TRAF3	NULL
binds	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
,	NULL
including	NULL
LTB	NULL
receptor	NULL
,	NULL
CD40	NULL
,	NULL
and	NULL
the	NULL
p80	NULL
subunit	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
(	NULL
4	NULL
,	NULL
17	NULL
,	NULL
34	NULL
)	NULL
.	NULL

The	NULL
strong	NULL
association	NULL
with	NULL
CD40	NULL
is	NULL
striking	NULL
,	NULL
since	NULL
cross-linking	NULL
of	NULL
this	NULL
B-cell	NULL
surface	NULL
receptor	NULL
promotes	NULL
long-term	NULL
B-cell	NULL
growth	NULL
in	NULL
vitro	NULL
and	NULL
an	NULL
activated	NULL
B-cell	NULL
phenotype	NULL
very	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Recent	NULL
attention	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
particularly	NULL
the	NULL
proximal	NULL
44	NULL
amino	NULL
acids	NULL
(	NULL
aa	NULL
)	NULL
,	NULL
as	NULL
an	NULL
important	NULL
region	NULL
for	NULL
signal	NULL
transduction	NULL
and	NULL
B-cell	NULL
immortalization	NULL
.	NULL

The	NULL
first	NULL
231	NULL
aa	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
is	NULL
sufficient	NULL
to	NULL
immortalize	NULL
B	NULL
cells	NULL
as	NULL
shown	NULL
by	NULL
genetic	NULL
analyses	NULL
with	NULL
recombinant	NULL
EBV	NULL
,	NULL
and	NULL
the	NULL
proximal	NULL
44	NULL
amino	NULL
acids	NULL
of	NULL
the	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
aa	NULL
187	NULL
to	NULL
231	NULL
)	NULL
is	NULL
essential	NULL
for	NULL
B-cell	NULL
immortalization	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

aa	NULL
187	NULL
to	NULL
231	NULL
of	NULL
LMP1	NULL
is	NULL
also	NULL
sufficient	NULL
for	NULL
interacting	NULL
with	NULL
TRAF3	NULL
(	NULL
34	NULL
)	NULL
.	NULL

We	NULL
have	NULL
now	NULL
cloned	NULL
the	NULL
LMP1	NULL
homologs	NULL
from	NULL
baboon	NULL
and	NULL
rhesus	NULL
EBV	NULL
(	NULL
cercopithicine	NULL
herpesviruses	NULL
12	NULL
and	NULL
15	NULL
)	NULL
and	NULL
compared	NULL
these	NULL
related	NULL
viral	NULL
oncogenes	NULL
to	NULL
identify	NULL
TRAF3-binding	NULL
sites	NULL
in	NULL
this	NULL
critical	NULL
LMP1	NULL
domain	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
.	NULL

$	NULL
594	NULL
is	NULL
a	NULL
baboon	NULL
B-cell	NULL
line	NULL
derived	NULL
by	NULL
spontaneous	NULL
growth	NULL
from	NULL
baboon	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
infected	NULL
with	NULL
baboon	NULL
EBV	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
P.	NULL
Johnson	NULL
and	NULL
N.	NULL
Letvin	NULL
)	NULL
(	NULL
38	NULL
)	NULL
.	NULL

LCL8664	NULL
is	NULL
a	NULL
rhesus	NULL
B-cell	NULL
line	NULL
derived	NULL
from	NULL
a	NULL
retroorbital	NULL
tumor	NULL
in	NULL
a	NULL
rhesus	NULL
monkey	NULL
and	NULL
is	NULL
infected	NULL
with	NULL
a	NULL
rhesus	NULL
EBV	NULL
isolate	NULL
(	NULL
39	NULL
)	NULL
.	NULL

293	NULL
is	NULL
a	NULL
transformed	NULL
human	NULL
primary	NULL
embryonal	NULL
kidney	NULL
cell	NULL
line	NULL
.	NULL

DG75	NULL
is	NULL
an	NULL
EBV-negative	NULL
human	NULL
B-lymphoma	NULL
cell	NULL
line	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
S.	NULL
Speck	NULL
)	NULL
.	NULL

DNA	NULL
cloning	NULL
.	NULL

(	NULL
i	NULL
)	NULL
Genomic	NULL
cloning	NULL
.	NULL

High-molecular-weight	NULL
DNA	NULL
was	NULL
prepared	NULL
from	NULL
LCL8664	NULL
cells	NULL
induced	NULL
for	NULL
viral	NULL
replication	NULL
by	NULL
transfection	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
the	NULL
EBV	NULL
transactivator	NULL
,	NULL
BZLF1	NULL
.	NULL

Genomic	NULL
DNA	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
cloned	NULL
into	NULL
Bluescript	NULL
.	NULL

The	NULL
LCL8664	NULL
genomic	NULL
library	NULL
was	NULL
probed	NULL
with	NULL
a	NULL
baboon	NULL
EBV	NULL
DNA	NULL
clone	NULL
,	NULL
L8	NULL
,	NULL
which	NULL
is	NULL
homologous	NULL
to	NULL
the	NULL
EBV	NULL
BamHI	NULL
Nhet	NULL
DNA	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Filters	NULL
were	NULL
washed	NULL
at	NULL
50Â°C	NULL
in	NULL
1	NULL
%	NULL
and	NULL
0.5	NULL
%	NULL
SSC	NULL
(	NULL
1	NULL
%	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
,	NULL
and	NULL
a	NULL
9-kb	NULL
rhesus	NULL
EBV	NULL
genomic	NULL
DNA	NULL
fragment	NULL
(	NULL
RE1	NULL
)	NULL
homologous	NULL
to	NULL
the	NULL
EBV	NULL
genome	NULL
coordinates	NULL
between	NULL
160744	NULL
and	NULL
169742	NULL
was	NULL
cloned	NULL
.	NULL

The	NULL
spliced	NULL
rhesus	NULL
LMP1	NULL
sequence	NULL
was	NULL
deduced	NULL
by	NULL
sequencing	NULL
the	NULL
portion	NULL
of	NULL
RE1	NULL
representing	NULL
the	NULL
LMP1	NULL
coding	NULL
region	NULL
between	NULL
EBV	NULL
coordinates	NULL
169208	NULL
and	NULL
168966	NULL
.	NULL

Splice	NULL
sites	NULL
were	NULL
confirmed	NULL
by	NULL
cloning	NULL
and	NULL
sequencing	NULL
reverse	NULL
transcription-PCR	NULL
amplification	NULL
products	NULL
from	NULL
LCL8664	NULL
RNA	NULL
.	NULL

(	NULL
ii	NULL
)	NULL
cDNA	NULL
cloning	NULL
.	NULL

A	NULL
2.4-kb	NULL
partial	NULL
baboon	NULL
LMP1	NULL
cDNA	NULL
was	NULL
cloned	NULL
by	NULL
screening	NULL
a	NULL
cDNA	NULL
library	NULL
constructed	NULL
from	NULL
$	NULL
594	NULL
polyadenylated	NULL
RNA	NULL
with	NULL
the	NULL
L8	NULL
DNA	NULL
clone	NULL
under	NULL
stringent	NULL
conditions	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Sequencing	NULL
of	NULL
the	NULL
partial	NULL
cDNA	NULL
indicates	NULL
that	NULL
its	NULL
5	NULL
``	NULL
end	NULL
corresponds	NULL
to	NULL
Ala-59	NULL
of	NULL
the	NULL
EBV	NULL
LMP1	NULL
.	NULL

The	NULL
human	NULL
,	NULL
baboon	NULL
,	NULL
and	NULL
rhesus	NULL
LMP1	NULL
genes	NULL
are	NULL
positionally	NULL
conserved	NULL
in	NULL
the	NULL
EBV	NULL
genomes	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
the	NULL
sequence	NULL
homology	NULL
of	NULL
the	NULL
surrounding	NULL
noncoding	NULL
regions	NULL
as	NULL
originally	NULL
suggested	NULL
by	NULL
the	NULL
studies	NULL
of	NULL
Heller	NULL
et	NULL
al	NULL
.	NULL

(	NULL
14	NULL
)	NULL
.	NULL

(	NULL
iii	NULL
)	NULL
Eukaryotic	NULL
expression	NULL
vectors	NULL
.	NULL

The	NULL
baboon	NULL
LMP1	NULL
partial	NULL
cDNA	NULL
and	NULL
a	NULL
3.6-kb	NULL
RE1	NULL
fragment	NULL
containing	NULL
the	NULL
coding	NULL
region	NULL
for	NULL
rhesus	NULL
LMP1	NULL
were	NULL
cloned	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
early	NULL
promoter	NULL
in	NULL
pSG5	NULL
(	NULL
Stratagene	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
amplified	NULL
with	NULL
a	NULL
common	NULL
5	NULL
'	NULL
primer	NULL
(	NULL
GAAGATCTCATGACACCCCCACTGAC	NULL
)	NULL
paired	NULL
with	NULL
one	NULL
of	NULL
two	NULL
3	NULL
'	NULL
primers	NULL
(	NULL
GAAGATCTCTAGGCATAGTAGCTC	NULL
ATT	NULL
or	NULL
GAAGATCTCTAATCITTCTGGTCCGTGGTTT	NULL
)	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
J.	NULL
ViRoL	NULL
.	NULL

expression	NULL
vector	NULL
pSFneo	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
A.	NULL
Weiss	NULL
and	NULL
T.	NULL
deFranco	NULL
[	NULL
20	NULL
]	NULL
)	NULL
to	NULL
produce	NULL
a	NULL
CD8	NULL
fusion	NULL
protein	NULL
consisting	NULL
of	NULL
the	NULL
CD8	NULL
transmembrane	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
baboon	NULL
EBV	NULL
LMP1	NULL
with	NULL
and	NULL
without	NULL
the	NULL
terminal	NULL
12	NULL
amino	NULL
acids	NULL
.	NULL

Each	NULL
fusion	NULL
protein	NULL
construct	NULL
was	NULL
sequenced	NULL
to	NULL
confirm	NULL
the	NULL
fidelity	NULL
of	NULL
the	NULL
amplification	NULL
and	NULL
cloning	NULL
.	NULL

The	NULL
pSFneo	NULL
expression	NULL
vector	NULL
containing	NULL
the	NULL
CD8	NULL
transmembrane	NULL
domain	NULL
fused	NULL
to	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
the	NULL
immunoglobulin	NULL
alpha	NULL
chain	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

GST	NULL
fusion	NULL
protein	NULL
expression	NULL
and	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
.	NULL

The	NULL
cytoplasmic	NULL
tail	NULL
of	NULL
the	NULL
rhesus	NULL
LMP1	NULL
homolog	NULL
starting	NULL
at	NULL
His-185	NULL
was	NULL
amplified	NULL
by	NULL
PCR	NULL
with	NULL
two	NULL
primers	NULL
with	NULL
flanking	NULL
BamHI	NULL
and	NULL
EcoRI	NULL
sites	NULL
(	NULL
5Â°	NULL
CGGGATCCCATGATTTC	NULL
AACCGTGC	NULL
3	NULL
'	NULL
and	NULL
5Â°	NULL
CGGGAATTCCCTCTCAGTCGTAGTAGCTGA	NULL
3	NULL
``	NULL
)	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
BamHI-EcoRI	NULL
site	NULL
of	NULL
the	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
protein	NULL
vector	NULL
pGEX	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
baboon	NULL
LMP1	NULL
homolog	NULL
starting	NULL
at	NULL
His-129	NULL
was	NULL
cloned	NULL
into	NULL
EcoRI	NULL
sites	NULL
of	NULL
pGEX	NULL
in	NULL
a	NULL
similar	NULL
manner	NULL
with	NULL
the	NULL
primer	NULL
pair	NULL
5Â°	NULL
CGGGAATTCATGACACCCCCA	NULL
CTGAC	NULL
3	NULL
'	NULL
and	NULL
5Â°	NULL
CGGGAATTCCAGGTTGAAACAACTCAG	NULL
3	NULL
'	NULL
.	NULL

The	NULL
187-aa	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD30	NULL
was	NULL
obtained	NULL
by	NULL
reverse	NULL
transcription-PCR	NULL
of	NULL
RNA	NULL
from	NULL
a	NULL
human	NULL
B-cell	NULL
line	NULL
with	NULL
CD3O-specific	NULL
primers	NULL
with	NULL
flanking	NULL
BemHI	NULL
(	NULL
sense	NULL
;	NULL
5Â°	NULL
GCGGGATCCCACCGGAGGGCCTGCAGGAAG	NULL
3	NULL
'	NULL
)	NULL
and	NULL
EcoRI	NULL
(	NULL
antisense	NULL
;	NULL
5Â°	NULL
CGCGAATTCCTTACTTTCCAGAGGCAGCTGTGG	NULL
3	NULL
``	NULL
)	NULL
sites	NULL
.	NULL

Specific	NULL
regions	NULL
from	NULL
the	NULL
simian	NULL
EBV	NULL
LMP	NULL
1s	NULL
and	NULL
CD30	NULL
were	NULL
cloned	NULL
into	NULL
pGEX	NULL
with	NULL
two	NULL
overlapping	NULL
oligomers	NULL
and	NULL
denatured	NULL
at	NULL
95Â°C	NULL
,	NULL
annealed	NULL
at	NULL
50Â°C	NULL
,	NULL
and	NULL
extended	NULL
at	NULL
72Â°C	NULL
with	NULL
Taq	NULL
DNA	NULL
polymerase	NULL
for	NULL
three	NULL
cycles	NULL
.	NULL

The	NULL
sense	NULL
primers	NULL
included	NULL
a	NULL
BamHI	NULL
site	NULL
and	NULL
the	NULL
antisense	NULL
primer	NULL
included	NULL
a	NULL
translational	NULL
stop	NULL
codon	NULL
and	NULL
an	NULL
EcoRI	NULL
site	NULL
to	NULL
facilitate	NULL
cloning	NULL
into	NULL
the	NULL
BamHI-EcoRI	NULL
cloning	NULL
site	NULL
of	NULL
pGEX	NULL
.	NULL

The	NULL
amino	NULL
acid	NULL
residues	NULL
included	NULL
in	NULL
these	NULL
recombinant	NULL
GST	NULL
fusion	NULL
proteins	NULL
from	NULL
baboon	NULL
and	NULL
rhesus	NULL
EBV	NULL
are	NULL
indicated	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

All	NULL
recombinant	NULL
DNA	NULL
constructs	NULL
were	NULL
confirmed	NULL
by	NULL
sequence	NULL
analysis	NULL
(	NULL
Sequenase	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

Radiolabelled	NULL
TRAF3	NULL
was	NULL
prepared	NULL
by	NULL
in	NULL
vitro	NULL
transcription-translation	NULL
with	NULL
a	NULL
2	NULL
4-kb	NULL
cDNA	NULL
encoding	NULL
TRAF3	NULL
and	NULL
the	NULL
TnT	NULL
T7-coupled	NULL
reticulocyte	NULL
lysate	NULL
system	NULL
from	NULL
Promega	NULL
as	NULL
specified	NULL
by	NULL
the	NULL
manufacturer	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
vitro	NULL
GST-binding	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
by	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
.	NULL

Transfection	NULL
,	NULL
CAT	NULL
assays	NULL
,	NULL
and	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
anal-ysis	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
electroporation	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

For	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
jpg	NULL
of	NULL
a	NULL
NF-	NULL
Â«	NULL
B-inducible	NULL
CAT	NULL
reporter	NULL
construct	NULL
(	NULL
containing	NULL
three	NULL
NF-	NULL
Â«	NULL
B-binding	NULL
sites	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter-driven	NULL
CAT	NULL
gene	NULL
)	NULL
;	NULL
10	NULL
ug	NULL
of	NULL
a	NULL
plasmid	NULL
containing	NULL
either	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
promoter-driven	NULL
human	NULL
,	NULL
baboon	NULL
,	NULL
or	NULL
rhesus	NULL
LMP1	NULL
gene	NULL
or	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
carly	NULL
promoter	NULL
alone	NULL
;	NULL
and	NULL
10	NULL
pg	NULL
of	NULL
a	NULL
simian	NULL
virus	NULL
40-driven	NULL
B-galactosidase	NULL
gene	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
measuring	NULL
the	NULL
B-galactosidase	NULL
activity	NULL
,	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
45	NULL
)	NULL
.	NULL

For	NULL
FACS	NULL
analysis	NULL
of	NULL
ICAM1	NULL
induction	NULL
,	NULL
10	NULL
``	NULL
DG75	NULL
cells	NULL
were	NULL
cotransfected	NULL
with	NULL
15	NULL
g	NULL
of	NULL
a	NULL
CD2	NULL
expression	NULL
vector	NULL
(	NULL
pB2	NULL
;	NULL
kindly	NULL
provided	NULL
by	NULL
Linda	NULL
Clayton	NULL
)	NULL
and	NULL
15	NULL
pg	NULL
of	NULL
control	NULL
vector	NULL
or	NULL
simian	NULL
LMP1	NULL
expression	NULL
vector	NULL
DNA	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
18-	NULL
to	NULL
24-h	NULL
incubations	NULL
,	NULL
viable	NULL
cells	NULL
were	NULL
harvested	NULL
over	NULL
a	NULL
Ficoll-Hypaque	NULL
gradient	NULL
and	NULL
stained	NULL
for	NULL
CD2	NULL
expression	NULL
with	NULL
an	NULL
anti-CD2	NULL
monoclonal	NULL
antibody	NULL
conjugated	NULL
to	NULL
phycoerythrin	NULL
(	NULL
T6.3	NULL
;	NULL
EXAlpha	NULL
)	NULL
and	NULL
for	NULL
ICAM1	NULL
expression	NULL
with	NULL
an	NULL
anti-CD54	NULL
monoclonal	NULL
antibody	NULL
(	NULL
15.2	NULL
;	NULL
Southern	NULL
Biotechnology	NULL
)	NULL
conjugated	NULL
to	NULL
fluorescein	NULL
isothiocyanate	NULL
.	NULL

Cells	NULL
transfected	NULL
with	NULL
the	NULL
CD8	NULL
fusion	NULL
proteins	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-CD8	NULL
monoclonal	NULL
antibody	NULL
(	NULL
17D8	NULL
;	NULL
EXAlpha	NULL
)	NULL
conjugated	NULL
to	NULL
phycoerythrin	NULL
.	NULL

Dual-color	NULL
surface	NULL
fluorescence	NULL
was	NULL
analyzed	NULL
on	NULL
a	NULL
Becton	NULL
Dickinson	NULL
FACScan	NULL
,	NULL
and	NULL
at	NULL
least	NULL
20,000	NULL
events	NULL
were	NULL
recorded	NULL
for	NULL
each	NULL
population	NULL
.	NULL

Controls	NULL
included	NULL
matched	NULL
isotype	NULL
control	NULL
antibodies	NULL
to	NULL
establish	NULL
negative	NULL
gates	NULL
and	NULL
cells	NULL
stained	NULL
with	NULL
a	NULL
single	NULL
fluorochrome	NULL
to	NULL
establish	NULL
appropriate	NULL
compensation	NULL
of	NULL
fluorochrome	NULL
bleedthrough	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
accession	NULL
numbers	NULL
.	NULL

The	NULL
nucleotide	NULL
sequences	NULL
for	NULL
the	NULL
partial	NULL
baboon	NULL
LMP1	NULL
cDNA	NULL
and	NULL
genomic	NULL
rhesus	NULL
EBV	NULL
DNA	NULL
containing	NULL
the	NULL
LMP1	NULL
coding	NULL
region	NULL
have	NULL
been	NULL
deposited	NULL
with	NULL
GenBank	NULL
under	NULL
accession	NULL
numbers	NULL
U45963	NULL
and	NULL
U45964	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
Carboxy-terminal	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
simian	NULL
EBV	NULL
LMP1s	NULL
show	NULL
marked	NULL
sequence	NULL
divergence	NULL
.	NULL

The	NULL
hydrophobic	NULL
membrane-spanning	NULL
domains	NULL
of	NULL
the	NULL
human	NULL
,	NULL
rhesus	NULL
,	NULL
and	NULL
baboon	NULL
EBV	NULL
LMP1	NULL
homologs	NULL
are	NULL
well	NULL
conserved	NULL
,	NULL
with	NULL
44	NULL
%	NULL
amino	NULL
acid	NULL
identity	NULL
among	NULL
all	NULL
three	NULL
genes	NULL
in	NULL
the	NULL
four	NULL
and	NULL
one-half	NULL
transmembrane	NULL
domains	NULL
where	NULL
sequences	NULL
from	NULL
all	NULL
three	NULL
are	NULL
available	NULL
for	NULL
comparison	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
sharp	NULL
contrast	NULL
,	NULL
the	NULL
sequences	NULL
of	NULL
all	NULL
three	NULL
genes	NULL
diverge	NULL
dramatically	NULL
in	NULL
the	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
with	NULL
only	NULL
a	NULL
few	NULL
isolated	NULL
regions	NULL
of	NULL
homology	NULL
.	NULL

Within	NULL
the	NULL
proximal	NULL
44	NULL
aa	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
there	NULL
is	NULL
a	NULL
region	NULL
of	NULL
similarity	NULL
among	NULL
all	NULL
three	NULL
genes	NULL
in	NULL
human	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
,	NULL
baboon	NULL
aa	NULL
241	NULL
to	NULL
252	NULL
,	NULL
and	NULL
rhesus	NULL
aa	NULL
337	NULL
to	NULL
348	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
is	NULL
striking	NULL
homology	NULL
at	NULL
the	NULL
extreme	NULL
carboxy	NULL
terminus	NULL
,	NULL
where	NULL
the	NULL
last	NULL
13	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
TRAF3	NULL
BINDING	NULL
SITES	NULL
IN	NULL
EBV	NULL
LMP1I	NULL
7821	NULL
A	NULL
Human	NULL
MEHDL	NULL
ERGP	NULL
PGP	NULL
RRPPREPP	NULL
LSSSTGLALLLLCLALLFWLY	NULL
IYHSDUTGGACEYTYSFALCMLTIITLIIFIpRRD	NULL
7s	NULL
Rhesus	NULL
MEGN-	NULL
-	NULL
RGRGGSNRHPRCPQPHASLLFGSLLLLYAILYWFEFIIMSDLTQTASTYLSSFAYYLITITITIMLFERR	NULL
73	NULL
Baboon	NULL
AIIMVVITIITIMLFGRR	NULL
17	NULL
*	NULL
...	NULL
..	NULL
'*	NULL
.	NULL

**	NULL
--	NULL
*n*	NULL
Huma	NULL
it	NULL
LLCPLGALCILLLMITLLLIALMN	NULL
LHGOALFLEIVLFTFECLLYLGTWIYL	NULL
LEMLWRLGATIWOLLAFFLAFFLD	NULL
159	NULL
Rhesus	NULL
LLCPLGLLCIILIMEIVILYSNULTLTGOTLEVG	NULL
LVI	NULL
LCLCT	NULL
LLALAYVWFYILMWL	NULL
LREYGASFWTEELAFCLAFLLA	NULL
148	NULL
Baboon	NULL
LLCPLGLLCLIFTVSALLTAMLWTLTEGYLEVETLELFLTLTLALLVWCYILMWLLRGLGASWWTIILSFCLAFELA	NULL
|	NULL
92	NULL
LE	NULL
ALLA	NULL
ii-ll	NULL
â	NULL
2.4	NULL
.	NULL

*	NULL
â	NULL
k	NULL
t1	NULL
.	NULL

*t	NULL
â	NULL
~k.l	NULL
``	NULL
.	NULL

*	NULL
.	NULL

*	NULL
'\l	NULL
â	NULL
ki	NULL
â	NULL
.	NULL

-*	NULL
.	NULL

K*	NULL
,	NULL
ow	NULL
Ik't	NULL
wok	NULL
%	NULL
Hunan	NULL
LILLIIALY	NULL
LAONWWTILLYDLLWLLLFLATLIMMYYR~~-	NULL
<	NULL
<	NULL
=	NULL
<	NULL
<	NULL
<	NULL
css	NULL
secs	NULL
s	NULL
es	NULL
eke	NULL
kk	NULL
casa	NULL
sabes	NULL
ess	NULL
187	NULL
Rhesus	NULL
TYVFLTIAYLLHLAWETYLYDLYWLLLELATLINIYYHOFNRATPEALANLEEEYNHOGHGHGGGOGOEKGPRVLL	NULL
223	NULL
Baboon	NULL
TYL	NULL
LTTAYL	NULL
HRCAWF	NULL
TII	NULL
LME	NULL
LE	NULL
LLE	NULL
=	NULL
--	NULL
=-	NULL
~~~	NULL
RGDEDDGAGGPPLLL	NULL
158	NULL
``	NULL
ti-it	NULL
.	NULL

*	NULL
.	NULL

,	NULL
.	NULL
*	NULL
.	NULL

*	NULL
.	NULL

*..	NULL
*	NULL
it'**li_itt	NULL
.	NULL

*	NULL
*	NULL
r-	NULL
Â»	NULL
cytoplasmi	NULL
Human	NULL
-GQRHSDEHHJ	NULL
?	NULL

?	NULL

Â¥1	NULL
?	NULL

?	NULL

?	NULL

E	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
197	NULL
Rhesus	NULL
-	NULL
=	NULL
==	NULL
-=~*~	NULL
HHHHHKNSNQGDPLGPYYSONGGNGGNEGDEGNRDGGNEDGGNGDGENYGDGGN	NULL
288	NULL
Babson	NULL
YGEDGPDNNNHTNPPYYYYLM-	NULL
=	NULL
Â«	NULL
==	NULL
a+	NULL
~-	NULL
Â«	NULL
ea	NULL
sak	NULL
444000009	NULL
e	NULL
eae	NULL
n	NULL
sateen	NULL
ce	NULL
eca	NULL
nes	NULL
noc	NULL
n	NULL
eek	NULL
s	NULL
179	NULL
a	NULL
>	NULL
-	NULL
;	NULL
;	NULL
-t	NULL
-	NULL
<	NULL
=n=	NULL
=t	NULL
ses	NULL
08	NULL
sac	NULL
DDSLPHPQOATODSG	NULL
212	NULL
Rhesus	NULL
GNGGNGDGGNGDGGNGDGENEG-	NULL
-	NULL
--	NULL
-	NULL
-	NULL
--	NULL
-+	NULL
~~	NULL
PDHLPYPIQATDEGNGGEGDEGNEGPDPLPYPIOATDGGN	NULL
350	NULL
Babson	NULL
253	NULL
*	NULL
Wok	NULL
ow	NULL
ow	NULL
Human	NULL
HESOSNSNEGRHELLYSGAGNGPPLCSQNLGAP-	NULL
--	NULL
-k	NULL
Â«	NULL
s=	NULL
GGGPDNGPQDPDNTDD~~~~-	NULL
--	NULL
261	NULL
Rhesus	NULL
|	NULL
~-	NULL
GDGD-~-~+	NULL
--	NULL
~~	NULL
--	NULL
GGNGGNGGGGGDPDHLPH-PTOATOGANSGE	NULL
390	NULL
Babgar	NULL
=	NULL
SCVGEG-	NULL
-	NULL
--	NULL
~~~~-GGPDODPHPPVOETGGGGSGYGGGGEPDODPHPPVOETGGGGSGY	NULL
304	NULL
2*	NULL
I	NULL
â	NULL
.l-	NULL
&	NULL
acte	NULL
|	NULL
ow	NULL
,	NULL
*20	NULL
%	NULL
2	NULL
...	NULL
HUMAM	NULL
-	NULL
nn	NULL
noma	NULL
n	NULL
e	NULL
#	NULL
4	NULL
<	NULL
no	NULL
no	NULL
nn	NULL
e	NULL
rR	NULL
a	NULL
coc	NULL
ono	NULL
o	NULL
ee	NULL
ee	NULL
de	NULL
con	NULL
onn	NULL
nn	NULL
ew	NULL
e	NULL
keno	NULL
n	NULL
conn	NULL
n	NULL
cee	NULL
ee	NULL
e	NULL
ke	NULL
coe	NULL
cnc	NULL
261	NULL
Rhesus	NULL
GCDGGDEEDGEGGGDRGPFAPYYSOGPSGDPOHLPHPMOASDGGDGLEPYGPAGPFTOGPSWPWGPFGTEPLEGPW	NULL
465	NULL
Baboon	NULL
GG6Â§	NULL
@	NULL
-	NULL
tn	NULL
ent	NULL
t	NULL
nnn	NULL
ae	NULL
ne-	NULL
ee	NULL
Ren	NULL
nnn	NULL
nes	NULL
eee	NULL
nen	NULL
e	NULL
nan	NULL
n	NULL
beeen	NULL
enemee	NULL
maa	NULL
eee	NULL
309	NULL
HUMAR	NULL
=	NULL
*	NULL
fft	NULL
sk	NULL
ass	NULL
NGPQDPDMN-~	NULL
--	NULL
~	NULL
--	NULL
-TODNGP	NULL
275	NULL
Rhesus	NULL
GPFGPGPCEPHGPWCENNNHG	NULL
E	NULL
LOETEE	NULL
SGPNMLLTLGGEGNSYHLNDIRGNGGNGPONPDN-	NULL
--	NULL
-	NULL
-	NULL
~~~	NULL
SNGSGP	NULL
532	NULL
Baboon	NULL
=	NULL
PDQDPMPPWGETGEGG-~~	NULL
+	NULL
<	NULL
=	NULL
<	NULL
=	NULL
=+	NULL
GGGSDGNQDPNHFPYYAQFHGDGGGG	NULL
351	NULL
~i	NULL
*-*	NULL
--	NULL
llcc	NULL
``	NULL
Human	NULL
HDPLPGDPDNTDDNGPQDPDNT	NULL
DDNGP	NULL
HDPLPHSPSDSAGNDGG-	NULL
--	NULL
--	NULL
-	NULL
-	NULL
PPQLTEEVENKGEDGGPPLMTDGG	NULL
343	NULL
Rhesus	NULL
GGPHNQQPESNEGG	NULL
@	NULL
PP	NULL
--	NULL
-	NULL
-	NULL
<	NULL
a	NULL
Â«	NULL
<	NULL
a	NULL
>	NULL
--	NULL
-	NULL
>	NULL
s	NULL
GPTDGEGNNEGPDSPP	NULL
--	NULL
~-~	NULL
--	NULL
~~~~-	NULL
SNQGPQ	NULL
--	NULL
--	NULL
--	NULL
569	NULL
Baboon	NULL
G	NULL
&	NULL
A-	NULL
--	NULL
nn	NULL
nnn	NULL
+	NULL
+	NULL
>	NULL
ro	NULL
SHPP	NULL
IOETGNSGGGNHGP	NULL
E+	NULL
--	NULL
-	NULL
--	NULL
<	NULL
-on	NULL
>	NULL
<	NULL
=	NULL
69	NULL
coco	NULL
-	NULL
>	NULL
375	NULL
2	NULL
.	NULL

Jok	NULL
,	NULL
*	NULL
.	NULL

,	NULL
*	NULL
Human	NULL
GGHSHDSGHEGGDPHLPTLLLESSGSGGDODDPHGPVOLSYYD	NULL
386	NULL
Rhesus	NULL
|	NULL
GPEGCÂ°GDPADFIQLSYYD	NULL
586	NULL
BaBQQM	NULL
=	NULL
DDPHGPVOMSYYA	NULL
389	NULL
.	NULL

,	NULL
*	NULL
#	NULL
li_l'_i	NULL
:	NULL
**_	NULL
B	NULL
ta	NULL
TM	NULL
Cyto	NULL
NH	NULL
,	NULL
1	NULL
14	NULL
T	NULL
~1	NULL
COOH	NULL
B	NULL
C	NULL
Ey	NULL
iif	NULL
4	NULL
LMP	NULL
]	NULL
if	NULL
A	NULL
B	NULL
_C	NULL
D	NULL
E	NULL
F	NULL
Rhesus	NULL
F	NULL
LMP1	NULL
|	NULL
A	NULL
B	NULL
CiC	NULL
:	NULL
DE	NULL
Baboon	NULL
Pil	NULL
SEH	NULL
Mo	NULL
LMP	NULL
]	NULL
h	NULL
1	NULL
1	NULL
t	NULL
1	NULL
1	NULL
1	NULL
I	NULL
0	NULL
100	NULL
200	NULL
300	NULL
400	NULL
500	NULL
600	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Amino	NULL
acid	NULL
alignment	NULL
of	NULL
human	NULL
LMP1	NULL
(	NULL
B95-8	NULL
strain	NULL
)	NULL
with	NULL
the	NULL
full-length	NULL
rhesus	NULL
and	NULL
partial	NULL
baboon	NULL
LMP1	NULL
sequence	NULL
.	NULL

Hydrophobic	NULL
transmembrane	NULL
domains	NULL
are	NULL
boxed	NULL
,	NULL
and	NULL
the	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

Identical	NULL
amino	NULL
acid	NULL
residues	NULL
conserved	NULL
in	NULL
all	NULL
three	NULL
genes	NULL
are	NULL
indicated	NULL
by	NULL
asterisks	NULL
,	NULL
and	NULL
conserved	NULL
residues	NULL
in	NULL
all	NULL
three	NULL
genes	NULL
are	NULL
indicated	NULL
by	NULL
dots	NULL
.	NULL

Regions	NULL
with	NULL
PXQXT/S	NULL
core	NULL
sequences	NULL
are	NULL
underlined	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Graphical	NULL
representation	NULL
of	NULL
human	NULL
and	NULL
simian	NULL
LMP1	NULL
proteins	NULL
.	NULL

Transmembrane	NULL
(	NULL
TM	NULL
)	NULL
domains	NULL
are	NULL
indicated	NULL
by	NULL
stippled	NULL
boxes	NULL
.	NULL

Regions	NULL
with	NULL
PXQXT/S	NULL
core	NULL
sequences	NULL
are	NULL
identified	NULL
by	NULL
solid	NULL
boxes	NULL
and	NULL
labeled	NULL
in	NULL
alphabetical	NULL
order	NULL
.	NULL

The	NULL
conserved	NULL
carboxy-terminal	NULL
PXQXT/S	NULL
core	NULL
sequences	NULL
with	NULL
tyrosine	NULL
repeats	NULL
are	NULL
identified	NULL
by	NULL
hatched	NULL
boxes	NULL
.	NULL

amino	NULL
acids	NULL
are	NULL
58	NULL
%	NULL
identical	NULL
and	NULL
92	NULL
%	NULL
similar	NULL
across	NULL
all	NULL
three	NULL
genes	NULL
.	NULL

The	NULL
alignment	NULL
of	NULL
the	NULL
simian	NULL
LMP1s	NULL
with	NULL
human	NULL
LMP1	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
reveals	NULL
a	NULL
common	NULL
P	NULL
(	NULL
X	NULL
)	NULL
Q	NULL
(	NULL
X	NULL
)	NULL
T	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
shared	NULL
sequence	NULL
can	NULL
be	NULL
extended	NULL
upstream	NULL
to	NULL
D	NULL
(	NULL
XX	NULL
)	NULL
P	NULL
(	NULL
X	NULL
)	NULL
P	NULL
(	NULL
X	NULL
)	NULL
Q	NULL
(	NULL
X	NULL
)	NULL
T	NULL
if	NULL
spacing	NULL
is	NULL
introduced	NULL
into	NULL
the	NULL
baboon	NULL
LMP1	NULL
sequence	NULL
.	NULL

A	NULL
number	NULL
of	NULL
similar	NULL
regions	NULL
with	NULL
a	NULL
PXQXT	NULL
core	NULL
sequence	NULL
can	NULL
be	NULL
identified	NULL
throughout	NULL
the	NULL
LMP1	NULL
cytoplasmic	NULL
domains	NULL
.	NULL

The	NULL
baboon	NULL
PXQXT	NULL
region	NULL
homologous	NULL
to	NULL
human	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
is	NULL
the	NULL
first	NULL
of	NULL
four	NULL
regions	NULL
(	NULL
aa	NULL
241	NULL
to	NULL
252	NULL
,	NULL
aa	NULL
263	NULL
to	NULL
276	NULL
,	NULL
aa	NULL
287	NULL
to	NULL
300	NULL
,	NULL
and	NULL
aa	NULL
311	NULL
to	NULL
324	NULL
)	NULL
which	NULL
lie	NULL
within	NULL
perfect	NULL
or	NULL
near-perfect	NULL
24-aa	NULL
and	NULL
72-nucleotide	NULL
repeats	NULL
.	NULL

The	NULL
last	NULL
13	NULL
amino	NULL
acids	NULL
at	NULL
the	NULL
carboxy	NULL
terminus	NULL
of	NULL
all	NULL
three	NULL
LMP1s	NULL
contain	NULL
a	NULL
similar	NULL
PXQXT	NULL
sequence	NULL
,	NULL
where	NULL
serine	NULL
has	NULL
been	NULL
substituted	NULL
for	NULL
threonine	NULL
followed	NULL
by	NULL
conserved	NULL
double	NULL
tyrosine	NULL
residues	NULL
.	NULL

A	NULL
total	NULL
of	NULL
six	NULL
and	NULL
eight	NULL
PXQXT/S-containing	NULL
regions	NULL
can	NULL
be	NULL
identified	NULL
in	NULL
the	NULL
rhesus	NULL
and	NULL
baboon	NULL
LMP1	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
these	NULL
are	NULL
numbered	NULL
arbitrarily	NULL
from	NULL
proximal	NULL
to	NULL
distal	NULL
by	NULL
letter	NULL
,	NULL
illustrated	NULL
graphically	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
;	NULL
the	NULL
sequences	NULL
for	NULL
each	NULL
region	NULL
are	NULL
compared	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

Rhesus	NULL
and	NULL
baboon	NULL
LMP1s	NULL
induce	NULL
NF-KB	NULL
activity	NULL
in	NULL
human	NULL
cells	NULL
similar	NULL
to	NULL
human	NULL
LMP1	NULL
.	NULL

We	NULL
asked	NULL
if	NULL
the	NULL
simian	NULL
LMP1s	NULL
with	NULL
divergent	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domains	NULL
could	NULL
still	NULL
induce	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
in	NULL
human	NULL
cells	NULL
similar	NULL
to	NULL
that	NULL
de	NULL
7822	NULL
FRANKEN	NULL
ET	NULL
AL	NULL
.	NULL

TABLE	NULL
1	NULL
.	NULL

TRAF	NULL
3	NULL
binding	NULL
in	NULL
vitro	NULL
by	NULL
PXQXT/S-containing	NULL
regions	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domains	NULL
of	NULL
rhesus	NULL
and	NULL
baboon	NULL
LMP1	NULL
vis	NULL
yp	NULL
Amino	NULL
Muta-	NULL
Sequence	NULL
``	NULL
TRAF	NULL
}	NULL
origin	NULL
acid	NULL
``	NULL
_	NULL
tion	NULL
binding	NULL
``	NULL
Rhesus	NULL
A	NULL
312	NULL
DHLPYPIQATDG	NULL
ND	NULL
Rhesus	NULL
B	NULL
337	NULL
DPLPYPIQATDG	NULL
++++	NULL
Rhesus	NULL
C	NULL
374	NULL
DHLPHPIQATDG	NULL
++++	NULL
Rhesus	NULL
C	NULL
(	NULL
PAA	NULL
)	NULL
374	NULL
P	NULL
-A	NULL
DHLPHAIQATDG	NULL
+	NULL
Rhesus	NULL
C	NULL
(	NULL
QAA	NULL
)	NULL
374	NULL
Q	NULL
-A	NULL
DHLPHPIAATDG	NULL
+	NULL
Rhesus	NULL
C	NULL
(	NULL
TAA	NULL
)	NULL
374	NULL
T-	NULL
A	NULL
DHLPHPIQAADG	NULL
+	NULL
Rhesus	NULL
D	NULL
422	NULL
DHLPHPVQASDG	NULL
++++	NULL
Rhesus	NULL
E	NULL
480	NULL
NNNHGPLOETGP	NULL
Rhesus	NULL
F	NULL
575	NULL
GDPADPIQISYYD	NULL
Baboon	NULL
A	NULL
201	NULL
DPLRTPVQESGY	NULL
++++	NULL
Baboon	NULL
B	NULL
215	NULL
PPNPRPPVQETGGG	NULL
++++	NULL
Baboon	NULL
C1	NULL
241	NULL
DQDPHPPVQETGGG	NULL
++++	NULL
Baboon	NULL
C2	NULL
263	NULL
DQDPHPPVQETGGG	NULL
Identical	NULL
to	NULL
C1	NULL
Baboon	NULL
C3	NULL
287	NULL
DQDPHPPVQETGGG	NULL
Identical	NULL
to	NULL
C1	NULL
Baboon	NULL
C4	NULL
311	NULL
DQDPHPPVQETGEG	NULL
ND	NULL
Baboon	NULL
D	NULL
355	NULL
GPPSHPPIQETGNG	NULL
ND	NULL
Baboon	NULL
E.	NULL
376	NULL
DPHGPVQMSYYA	NULL
Human	NULL
A	NULL
199	NULL
DSLPHPQQATDDSGHE	NULL
4bÂ°	NULL
*	NULL
Amino	NULL
acid	NULL
residues	NULL
of	NULL
the	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
from	NULL
each	NULL
herpesvirus	NULL
fused	NULL
to	NULL
GST	NULL
are	NULL
shown	NULL
with	NULL
the	NULL
amino	NULL
acid	NULL
number	NULL
of	NULL
the	NULL
first	NULL
residue	NULL
indicated	NULL
.	NULL

Â®	NULL
Average	NULL
binding	NULL
of	NULL
input	NULL
TRAF3	NULL
from	NULL
multiple	NULL
assays	NULL
is	NULL
indicated	NULL
by	NULL
++++	NULL
(	NULL
>	NULL
50	NULL
%	NULL
)	NULL
,	NULL
+++	NULL
(	NULL
30	NULL
to	NULL
50	NULL
%	NULL
)	NULL
,	NULL
++	NULL
(	NULL
20	NULL
to	NULL
30	NULL
%	NULL
)	NULL
,	NULL
+	NULL
(	NULL
10	NULL
to	NULL
20	NULL
%	NULL
)	NULL
,	NULL
+	NULL
(	NULL
1	NULL
to	NULL
10	NULL
%	NULL
)	NULL
,	NULL
and	NULL
-	NULL
(	NULL
<	NULL
1.0	NULL
%	NULL
)	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

Â©	NULL
Reference	NULL
for	NULL
data	NULL
for	NULL
the	NULL
human	NULL
LMP1	NULL
sequence	NULL
.	NULL

scribed	NULL
for	NULL
human	NULL
LMP1	NULL
(	NULL
12	NULL
,	NULL
24	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
rhesus	NULL
genomic	NULL
and	NULL
baboon	NULL
cDNA	NULL
clones	NULL
containing	NULL
the	NULL
LMP1	NULL
coding	NULL
regions	NULL
were	NULL
cotransfected	NULL
into	NULL
293	NULL
cells	NULL
with	NULL
an	NULL
NF-kB	NULL
reporter	NULL
plasmid	NULL
containing	NULL
three	NULL
NF-	NULL
Â«	NULL
B	NULL
elements	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
.	NULL

Human	NULL
LMP1	NULL
expression	NULL
results	NULL
in	NULL
a	NULL
greater	NULL
than	NULL
fourfold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
compared	NULL
with	NULL
the	NULL
reporter	NULL
construct	NULL
cotransfected	NULL
with	NULL
vector	NULL
control	NULL
plasmid	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
either	NULL
the	NULL
rhesus	NULL
or	NULL
baboon	NULL
LMP1	NULL
expression	NULL
plasmids	NULL
with	NULL
the	NULL
NF-kB	NULL
reporter	NULL
construct	NULL
results	NULL
in	NULL
a	NULL
similar	NULL
four-	NULL
to	NULL
five-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
with	NULL
respect	NULL
to	NULL
vector	NULL
control	NULL
cotransfection	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
is	NULL
due	NULL
to	NULL
increased	NULL
NF-KB	NULL
activity	NULL
because	NULL
the	NULL
same	NULL
constructs	NULL
cotransfected	NULL
with	NULL
an	NULL
identical	NULL
reporter	NULL
construct	NULL
lacking	NULL
the	NULL
NF-	NULL
Â«	NULL
B	NULL
sites	NULL
did	NULL
not	NULL
result	NULL
in	NULL
increased	NULL
CAT	NULL
activity	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
is	NULL
specific	NULL
for	NULL
LMP1	NULL
because	NULL
cotransfection	NULL
of	NULL
human	NULL
or	NULL
baboon	NULL
LMP2A	NULL
with	NULL
the	NULL
NF-kB	NULL
reporter	NULL
plasmid	NULL
has	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
CAT	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
human	NULL
,	NULL
baboon	NULL
,	NULL
and	NULL
rhesus	NULL
LMP1	NULL
genes	NULL
share	NULL
the	NULL
ability	NULL
to	NULL
induce	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
in	NULL
human	NULL
cells	NULL
.	NULL

Binding	NULL
of	NULL
human	NULL
TRAF3	NULL
by	NULL
the	NULL
rhesus	NULL
and	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

We	NULL
used	NULL
an	NULL
in	NULL
vitro	NULL
binding	NULL
assay	NULL
to	NULL
find	NULL
whether	NULL
the	NULL
divergent	NULL
cytoplasmic	NULL
LMP1	NULL
domains	NULL
of	NULL
the	NULL
simian	NULL
EBVs	NULL
also	NULL
retain	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
human	NULL
TRAF3	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Radiolabeled	NULL
human	NULL
TRAF3	NULL
from	NULL
in	NULL
vitro	NULL
translation	NULL
of	NULL
a	NULL
full-length	NULL
cDNA	NULL
clone	NULL
was	NULL
incubated	NULL
with	NULL
Sepharose	NULL
beads	NULL
coupled	NULL
to	NULL
GST	NULL
proteins	NULL
fused	NULL
with	NULL
the	NULL
entire	NULL
rhesus	NULL
or	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

No	NULL
TRAF3	NULL
is	NULL
bound	NULL
by	NULL
the	NULL
beads	NULL
containing	NULL
the	NULL
GST	NULL
control	NULL
protein	NULL
,	NULL
but	NULL
both	NULL
rhesus	NULL
and	NULL
baboon	NULL
LMP1	NULL
cytoplasmic	NULL
domains	NULL
readily	NULL
bind	NULL
TRAF3	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Regions	NULL
of	NULL
12	NULL
to	NULL
14	NULL
aa	NULL
containing	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
bind	NULL
TRAF3	NULL
.	NULL

Devergne	NULL
et	NULL
al	NULL
.	NULL

have	NULL
recently	NULL
identified	NULL
that	NULL
the	NULL
TRAF3-binding	NULL
site	NULL
in	NULL
human	NULL
LMP1	NULL
maps	NULL
to	NULL
a	NULL
16-aa	NULL
J.	NULL
ViRoL	NULL
.	NULL

region	NULL
around	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
at	NULL
human	NULL
aa	NULL
199	NULL
to	NULL
214	NULL
(	NULL
4b	NULL
)	NULL
.	NULL

This	NULL
region	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
TRAF3-binding	NULL
rhesus	NULL
LMP1	NULL
regions	NULL
except	NULL
for	NULL
novel	NULL
residues	NULL
at	NULL
-3	NULL
,	NULL
+1	NULL
,	NULL
and	NULL
+6	NULL
.	NULL

We	NULL
asked	NULL
if	NULL
the	NULL
simian	NULL
LMP1	NULL
regions	NULL
aligning	NULL
with	NULL
the	NULL
human	NULL
aa	NULL
199	NULL
to	NULL
210	NULL
,	NULL
as	NULL
well	NULL
as	NULL
other	NULL
PXQXT/S-containing	NULL
regions	NULL
,	NULL
could	NULL
bind	NULL
TRAF3	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
12	NULL
aa	NULL
of	NULL
the	NULL
rhesus	NULL
B	NULL
,	NULL
C	NULL
,	NULL
D	NULL
,	NULL
and	NULL
E	NULL
regions	NULL
and	NULL
13	NULL
aa	NULL
of	NULL
the	NULL
rhesus	NULL
F	NULL
region	NULL
were	NULL
evaluated	NULL
by	NULL
the	NULL
in	NULL
vitro-translated	NULL
TRAF3-binding	NULL
assay	NULL
.	NULL

A	NULL
representative	NULL
experiment	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
and	NULL
multiple	NULL
experiments	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

The	NULL
rhesus	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
regions	NULL
all	NULL
bind	NULL
to	NULL
TRAF3	NULL
.	NULL

The	NULL
sequence	NULL
from	NULL
the	NULL
rhesus	NULL
D	NULL
region	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
C	NULL
region	NULL
except	NULL
for	NULL
a	NULL
valine	NULL
at	NULL
position	NULL
+1	NULL
and	NULL
a	NULL
serine	NULL
in	NULL
position	NULL
+4	NULL
relative	NULL
to	NULL
the	NULL
proline	NULL
in	NULL
PXQXT/S	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
serine	NULL
or	NULL
threonine	NULL
residue	NULL
at	NULL
+4	NULL
in	NULL
the	NULL
core	NULL
sequence	NULL
is	NULL
still	NULL
associated	NULL
with	NULL
TRAF3	NULL
binding	NULL
.	NULL

The	NULL
A	NULL
region	NULL
was	NULL
not	NULL
directly	NULL
tested	NULL
,	NULL
since	NULL
it	NULL
is	NULL
identical	NULL
to	NULL
the	NULL
B	NULL
region	NULL
except	NULL
for	NULL
a	NULL
histidine	NULL
residue	NULL
at	NULL
-4	NULL
relative	NULL
to	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
,	NULL
and	NULL
experiments	NULL
with	NULL
the	NULL
B	NULL
and	NULL
C	NULL
regions	NULL
indicate	NULL
that	NULL
histidine	NULL
residues	NULL
at	NULL
both	NULL
positions	NULL
-1	NULL
and	NULL
-4	NULL
still	NULL
allow	NULL
for	NULL
TRAF3	NULL
binding	NULL
.	NULL

The	NULL
E	NULL
region	NULL
fails	NULL
to	NULL
bind	NULL
TRAF3	NULL
and	NULL
contains	NULL
several	NULL
differences	NULL
from	NULL
the	NULL
other	NULL
rhesus	NULL
regions	NULL
,	NULL
including	NULL
a	NULL
glutamic	NULL
acid	NULL
at	NULL
+3	NULL
and	NULL
several	NULL
residues	NULL
upstream	NULL
of	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
.	NULL

We	NULL
tested	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
proline	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
threonine/serine	NULL
residues	NULL
in	NULL
the	NULL
core	NULL
sequence	NULL
of	NULL
these	NULL
homologous	NULL
regions	NULL
by	NULL
mutating	NULL
each	NULL
position	NULL
individually	NULL
within	NULL
the	NULL
rhesus	NULL
C	NULL
region	NULL
to	NULL
determine	NULL
their	NULL
effect	NULL
on	NULL
TRAF3	NULL
binding	NULL
.	NULL

Mutating	NULL
the	NULL
proline	NULL
in	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
[	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
PAA	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
]	NULL
abrogates	NULL
most	NULL
of	NULL
the	NULL
TRAF3	NULL
binding	NULL
in	NULL
these	NULL
assays	NULL
.	NULL

In	NULL
multiple	NULL
experiments	NULL
,	NULL
the	NULL
mutant	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
PAA	NULL
protein	NULL
has	NULL
an	NULL
average	NULL
of	NULL
9	NULL
%	NULL
of	NULL
the	NULL
TRAF3-binding	NULL
activity	NULL
demonstrated	NULL
by	NULL
the	NULL
wild-type	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
construct	NULL
.	NULL

Mutation	NULL
of	NULL
either	NULL
the	NULL
glutamine	NULL
or	NULL
threonine	NULL
to	NULL
alanine	NULL
also	NULL
results	NULL
in	NULL
significant	NULL
reduction	NULL
of	NULL
TRAF3	NULL
binding	NULL
[	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
QAA	NULL
and	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
TAA	NULL
have	NULL
an	NULL
average	NULL
of	NULL
18	NULL
and	NULL
23	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
the	NULL
wild-type	NULL
GST-R	NULL
(	NULL
C	NULL
)	NULL
-binding	NULL
activity	NULL
]	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
leucine	NULL
at	NULL
-3	NULL
in	NULL
the	NULL
rhesus	NULL
C	NULL
region	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
TRAF3	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
data	NULL
support	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
proline	NULL
,	NULL
glutamine	NULL
,	NULL
and	NULL
threonine/serine	NULL
residues	NULL
represent	NULL
important	NULL
core	NULL
sites	NULL
within	NULL
these	NULL
conserved	NULL
regions	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
baboon	NULL
LMP1	NULL
regions	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C1	NULL
,	NULL
and	NULL
E	NULL
were	NULL
similarly	NULL
constructed	NULL
and	NULL
tested	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
proteins	NULL
with	NULL
12	NULL
aa	NULL
from	NULL
baboon	NULL
region	NULL
A	NULL
or	NULL
14	NULL
aa	NULL
from	NULL
region	NULL
B	NULL
or	NULL
C	NULL
all	NULL
bind	NULL
TRAF3	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
TRAF3	NULL
binding	NULL
by	NULL
baboon	NULL
region	NULL
A	NULL
provides	NULL
another	NULL
instance	NULL
in	NULL
which	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
contains	NULL
a	NULL
serine	NULL
at	NULL
position	NULL
+4	NULL
.	NULL

Baboon	NULL
TRAF3-binding	NULL
regions	NULL
have	NULL
a	NULL
glutamic	NULL
acid	NULL
at	NULL
position	NULL
+3	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
an	NULL
alanine	NULL
in	NULL
the	NULL
rhesus	NULL
TRAF3-binding	NULL
regions	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
substitution	NULL
is	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
TRAF3	NULL
binding	NULL
by	NULL
rhesus	NULL
region	NULL
E.	NULL
All	NULL
TRAF3-binding	NULL
regions	NULL
from	NULL
baboon	NULL
LMP1	NULL
contain	NULL
a	NULL
valine	NULL
at	NULL
position	NULL
+1	NULL
,	NULL
similar	NULL
to	NULL
rhesus	NULL
region	NULL
D	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
valine	NULL
can	NULL
be	NULL
paired	NULL
with	NULL
either	NULL
serine	NULL
or	NULL
threonine	NULL
in	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
.	NULL

A	NULL
PXQXT/S-containing	NULL
region	NULL
in	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
also	NULL
binds	NULL
TRAF3	NULL
.	NULL

CD30	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
both	NULL
EBV-infected	NULL
B	NULL
cells	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
6	NULL
)	NULL
.	NULL

There	NULL
is	NULL
a	NULL
PXQXT/S-containing	NULL
region	NULL
at	NULL
aa	NULL
561	NULL
in	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
which	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
baboon	NULL
LMP1	NULL
region	NULL
C	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

A	NULL
GST	NULL
fusion	NULL
protein	NULL
containing	NULL
the	NULL
entire	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
binds	NULL
TRAF3	NULL
in	NULL
vitro	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
mediates	NULL
this	NULL
binding	NULL
by	NULL
using	NULL
a	NULL
GST	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
Average	NULL
Reporter	NULL
plasmid	NULL
Effector	NULL
_	NULL
fold	NULL
stimulation	NULL
TK-CAT	NULL
vector	NULL
1	NULL
``	NULL
H-LMP1I	NULL
0.3	NULL
``	NULL
B-LMP1	NULL
0,5	NULL
``	NULL
R-LMP1	NULL
0.4	NULL
NFkB-TK-CAT	NULL
vector	NULL
1	NULL
``	NULL
H-LMP1	NULL
4.5	NULL
``	NULL
B-LMP1	NULL
4.6	NULL
``	NULL
R-LMP	NULL
1	NULL
4.0	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
by	NULL
human	NULL
and	NULL
simian	NULL
LMP1	NULL
in	NULL
human	NULL
293	NULL
cells	NULL
.	NULL

The	NULL
average	NULL
fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
from	NULL
three	NULL
experiments	NULL
is	NULL
shown	NULL
,	NULL
along	NULL
with	NULL
a	NULL
representative	NULL
assay	NULL
.	NULL

Extracts	NULL
for	NULL
CAT	NULL
assays	NULL
were	NULL
normalized	NULL
for	NULL
transfection	NULL
efficiency	NULL
by	NULL
a	NULL
B-galactosidase	NULL
assay	NULL
.	NULL

CAT	NULL
reporter	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
with	NULL
pSG5	NULL
vector	NULL
control	NULL
(	NULL
vector	NULL
)	NULL
and	NULL
pSGS	NULL
vectors	NULL
with	NULL
human	NULL
(	NULL
H-LMP1	NULL
)	NULL
,	NULL
baboon	NULL
(	NULL
B-LMP1	NULL
)	NULL
,	NULL
and	NULL
rhesus	NULL
(	NULL
R-LMP1	NULL
)	NULL
LMPL	NULL
fusion	NULL
protein	NULL
containing	NULL
only	NULL
17	NULL
aa	NULL
surrounding	NULL
the	NULL
core	NULL
sequence	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
fusion	NULL
protein	NULL
with	NULL
only	NULL
this	NULL
17	NULL
aa	NULL
of	NULL
CD30	NULL
binds	NULL
TRAF3	NULL
in	NULL
vitro	NULL
,	NULL
although	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
than	NULL
does	NULL
the	NULL
entire	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
average	NULL
of	NULL
78	NULL
%	NULL
versus	NULL
17	NULL
%	NULL
binding	NULL
of	NULL
input	NULL
TRAF3	NULL
)	NULL
.	NULL

A	NULL
direct	NULL
role	NULL
for	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
in	NULL
the	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
demonstrated	NULL
by	NULL
the	NULL
elimination	NULL
of	NULL
all	NULL
TRAF3	NULL
binding	NULL
when	NULL
the	NULL
glutamine	NULL
residue	NULL
is	NULL
mutated	NULL
to	NULL
an	NULL
alanine	NULL
(	NULL
<	NULL
0.1	NULL
%	NULL
[	NULL
Fig	NULL
.	NULL

4B	NULL
]	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
TRAF3-binding	NULL
regions	NULL
containing	NULL
a	NULL
PXQXT/S	NULL
66	NULL
kda	NULL
-	NULL
:	NULL
TRAF	NULL
:	NULL
45	NULL
kda	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

In	NULL
vitro	NULL
TRAF3-binding	NULL
assay	NULL
.	NULL

Radiolabeled	NULL
in	NULL
vitro-translated	NULL
TRAF3	NULL
was	NULL
precipitated	NULL
with	NULL
control	NULL
GST	NULL
fusion	NULL
protein	NULL
or	NULL
GST	NULL
proteins	NULL
fused	NULL
to	NULL
the	NULL
complete	NULL
baboon	NULL
(	NULL
GST-B-LMP1	NULL
)	NULL
or	NULL
rhesus	NULL
(	NULL
GST-R-LMP1	NULL
)	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

GST	NULL
proteins	NULL
were	NULL
also	NULL
fused	NULL
to	NULL
single	NULL
regions	NULL
containing	NULL
PXQXT/S	NULL
core	NULL
sequences	NULL
from	NULL
baboon	NULL
[	NULL
GST-B	NULL
(	NULL
A	NULL
through	NULL
E	NULL
)	NULL
]	NULL
and	NULL
rhesus	NULL
[	NULL
GST-R	NULL
(	NULL
A	NULL
through	NULL
F	NULL
)	NULL
]	NULL
LMP1	NULL
.	NULL

GST	NULL
proteins	NULL
in	NULL
which	NULL
alanine	NULL
residues	NULL
were	NULL
substituted	NULL
for	NULL
the	NULL
proline	NULL
,	NULL
glutamine	NULL
,	NULL
or	NULL
threonine	NULL
residue	NULL
of	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
are	NULL
indicated	NULL
by	NULL
PAA	NULL
,	NULL
QAA	NULL
,	NULL
and	NULL
TAA	NULL
,	NULL
respectively	NULL
.	NULL

TRAF3	NULL
BINDING	NULL
SITES	NULL
IN	NULL
EBV	NULL
LMPI	NULL
7823	NULL
A	NULL
GST-B	NULL
(	NULL
C	NULL
)	NULL
DODPHPPVQETCCG	NULL
GST-CD30-pep	NULL
ADHTPHYPEGQETEPPLG	NULL
GST-CD30-pepQAA	NULL
ADHTPHYBEARTEPPLG	NULL
66	NULL
kda-TRAF3	NULL
45	NULL
kda	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PXQXT/S-containing	NULL
region	NULL
from	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
compared	NULL
with	NULL
baboon	NULL
region	NULL
C	NULL
;	NULL
(	NULL
B	NULL
)	NULL
in	NULL
vitro	NULL
TRAF3-binding	NULL
assays	NULL
with	NULL
GST-CD30	NULL
fusion	NULL
proteins	NULL
.	NULL

GST	NULL
fusion	NULL
proteins	NULL
containing	NULL
the	NULL
complete	NULL
CD30	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
GST-CD30	NULL
)	NULL
,	NULL
the	NULL
region	NULL
containing	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
from	NULL
aa	NULL
561	NULL
to	NULL
577	NULL
of	NULL
CD30	NULL
(	NULL
GST-CD30-pep	NULL
)	NULL
,	NULL
or	NULL
the	NULL
same	NULL
region	NULL
with	NULL
the	NULL
glutamine	NULL
mutated	NULL
to	NULL
an	NULL
alanine	NULL
residue	NULL
(	NULL
GST-CD30-pepQAA	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

core	NULL
sequence	NULL
are	NULL
present	NULL
in	NULL
both	NULL
viral	NULL
and	NULL
cell	NULL
proteins	NULL
associated	NULL
with	NULL
malignant	NULL
transformation	NULL
.	NULL

Simian	NULL
LMP1s	NULL
can	NULL
induce	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
TNF-responsive	NULL
ICAM1	NULL
gene	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Conserved	NULL
TRAF3	NULL
binding	NULL
suggests	NULL
that	NULL
the	NULL
simian	NULL
LMP1s	NULL
should	NULL
be	NULL
capable	NULL
of	NULL
inducing	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
human	NULL
LMP1-	NULL
and	NULL
TNF-inducible	NULL
gene	NULL
such	NULL
as	NULL
ICAM1	NULL
(	NULL
31	NULL
,	NULL
35	NULL
,	NULL
37	NULL
,	NULL
44	NULL
,	NULL
46	NULL
)	NULL
.	NULL

LMP1	NULL
expression	NULL
vectors	NULL
were	NULL
cotransfected	NULL
with	NULL
a	NULL
CD2	NULL
expression	NULL
vector	NULL
into	NULL
the	NULL
EBV-negative	NULL
B-lymphoma	NULL
cell	NULL
line	NULL
DG75	NULL
to	NULL
test	NULL
for	NULL
the	NULL
effect	NULL
on	NULL
ICAM1	NULL
expression	NULL
.	NULL

Cell	NULL
surface	NULL
CD2	NULL
expression	NULL
was	NULL
used	NULL
to	NULL
identify	NULL
transiently	NULL
transfected	NULL
cells	NULL
,	NULL
most	NULL
of	NULL
which	NULL
will	NULL
have	NULL
been	NULL
cotransfected	NULL
with	NULL
LMP1	NULL
DNA	NULL
as	NULL
well	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
DG75	NULL
cells	NULL
express	NULL
a	NULL
low	NULL
level	NULL
of	NULL
cell	NULL
surface	NULL
ICAM1	NULL
in	NULL
untransfected	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
level	NULL
of	NULL
ICAM1	NULL
expression	NULL
is	NULL
unchanged	NULL
by	NULL
CD2	NULL
expression	NULL
when	NULL
cotransfected	NULL
with	NULL
the	NULL
vector	NULL
control	NULL
DNA	NULL
.	NULL

When	NULL
the	NULL
CD2	NULL
DNA	NULL
is	NULL
cotransfected	NULL
with	NULL
a	NULL
human	NULL
LMP1	NULL
expression	NULL
vector	NULL
,	NULL
ICAM1	NULL
is	NULL
induced	NULL
in	NULL
the	NULL
CD2-positive	NULL
cells	NULL
while	NULL
the	NULL
CD2-negative	NULL
cells	NULL
show	NULL
baseline	NULL
ICAM1	NULL
levels	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
rhesus	NULL
or	NULL
baboon	NULL
LMP1	NULL
expression	NULL
vector	NULL
activates	NULL
ICAM1	NULL
expression	NULL
to	NULL
levels	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
human	NULL
LMP1	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
CD2-positive	NULL
cells	NULL
in	NULL
human	NULL
LMP1	NULL
cotransfected	NULL
cells	NULL
is	NULL
consistently	NULL
reduced	NULL
and	NULL
may	NULL
reflect	NULL
the	NULL
previously	NULL
recognized	NULL
cell	NULL
toxicity	NULL
associated	NULL
with	NULL
high-level	NULL
LMP1	NULL
expression	NULL
(	NULL
13	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
cotransfection	NULL
with	NULL
rhesus	NULL
or	NULL
baboon	NULL
LMP1	NULL
consistently	NULL
results	NULL
in	NULL
CD2	NULL
transfection	NULL
effi-ciencies	NULL
comparable	NULL
to	NULL
or	NULL
higher	NULL
than	NULL
those	NULL
of	NULL
cells	NULL
cotransfected	NULL
with	NULL
vector	NULL
control	NULL
plasmid	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
simian	NULL
LMP1s	NULL
fail	NULL
to	NULL
demonstrate	NULL
the	NULL
cell	NULL
toxicity	NULL
typically	NULL
associated	NULL
with	NULL
high-level	NULL
LMP1	NULL
expression	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Signal	NULL
transduction	NULL
from	NULL
the	NULL
baboon	NULL
LMP1	NULL
cytoplasmic	NULL
domain	NULL
containing	NULL
multiple	NULL
TRAF3-binding	NULL
sites	NULL
does	NULL
not	NULL
require	NULL
LMP1	NULL
transmembrane	NULL
domains	NULL
or	NULL
patching	NULL
.	NULL

The	NULL
functional	NULL
activity	NULL
from	NULL
the	NULL
partial	NULL
baboon	NULL
cDNA	NULL
clone	NULL
suggests	NULL
that	NULL
intact	NULL
transmembrane	NULL
domains	NULL
are	NULL
not	NULL
required	NULL
for	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
baboon	NULL
LMP1	NULL
.	NULL

This	NULL
was	NULL
unexpected	NULL
since	NULL
similar	NULL
truncations	NULL
of	NULL
the	NULL
human	NULL
LMP1	NULL
transmembrane	NULL
domains	NULL
abrogate	NULL
patching	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
and	NULL
induction	NULL
of	NULL
cell	NULL
gene	NULL
expression	NULL
(	NULL
28	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
signal	NULL
transduction	NULL
from	NULL
the	NULL
baboon	NULL
LMP1	NULL
can	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
transmembrane	NULL
domains	NULL
,	NULL
the	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
was	NULL
fused	NULL
to	NULL
the	NULL
CD8	NULL
transmembrane	NULL
domain	NULL
.	NULL

Transfection	NULL
of	NULL
the	NULL
CD8-control	NULL
or	NULL
CD8-baboon	NULL
cytoplasmic	NULL
domain	NULL
results	NULL
in	NULL
a	NULL
typical	NULL
diffuse	NULL
surface	NULL
immunofluorescence	NULL
pattern	NULL
when	NULL
stained	NULL
with	NULL
an	NULL
anti-CD8	NULL
monoclonal	NULL
antibody	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
CD8-baboon	NULL
LMP1	NULL
cytoplasmic	NULL
fusion	NULL
7824	NULL
FRANKEN	NULL
ET	NULL
AL	NULL
.	NULL

Exp	NULL
#	NULL
Lo	NULL
2	NULL
1002	NULL
We	NULL
e	NULL
cells	NULL
68	NULL
%	NULL
3	NULL
gey	NULL
-	NULL
04	NULL
%	NULL
p	NULL
gy	NULL
,	NULL
A	NULL
Â»	NULL
19	NULL
%	NULL
3	NULL
5	NULL
%	NULL
,	NULL
16.0	NULL
%	NULL
94	NULL
%	NULL
-	NULL
]	NULL
a	NULL
8s	NULL
n	NULL
o	NULL
5	NULL
_o	NULL
T	NULL
No-	NULL
B	NULL
o	NULL
_o	NULL
T	NULL
T	NULL
Mean	NULL
Fluorescence	NULL
Intensity	NULL
ICAMI	NULL
O	NULL
o	NULL
0	NULL
&	NULL
B	NULL
2	NULL
Ae	NULL
:	NULL
CD2	NULL
-	NULL
=+	NULL
)	NULL
0	NULL
=k	NULL
00	NULL
=f	NULL
=	NULL
}	NULL
0	NULL
to	NULL
-+	NULL
A	NULL
.zt_	NULL
cole	NULL
Vector	NULL
H-LMPI	NULL
B-LMP1	NULL
R-LMPI	NULL
|	NULL
Mcan	NULL
Fluorescence	NULL
Intensity	NULL
ICAMI	NULL
cD	NULL
-	NULL
=pos=t	NULL
|	NULL
=p	NULL
=	NULL
}	NULL
o	NULL
-	NULL
}	NULL
-f	NULL
DG75	NULL
Nh	NULL
CDW	NULL
Cells	NULL
CD	NULL
&	NULL
AIga	NULL
_	NULL
CD	NULL
#	NULL
/B-LMPL	NULL
p	NULL
rypjap	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Induction	NULL
of	NULL
ICAM1	NULL
cell	NULL
surface	NULL
expression	NULL
in	NULL
DG75	NULL
cells	NULL
after	NULL
CD2	NULL
cotransfection	NULL
with	NULL
human	NULL
and	NULL
simian	NULL
LMP1	NULL
(	NULL
A	NULL
)	NULL
or	NULL
cotransfection	NULL
with	NULL
CD8-baboon	NULL
LMP1	NULL
fusion	NULL
constructs	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Surface	NULL
expression	NULL
of	NULL
ICAM1	NULL
on	NULL
untransfected	NULL
DG75	NULL
cells	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
open	NULL
bars	NULL
.	NULL

ICAM1	NULL
expression	NULL
on	NULL
CD2-positive	NULL
(	NULL
solid	NULL
bars	NULL
)	NULL
or	NULL
-negative	NULL
(	NULL
stippled	NULL
bars	NULL
)	NULL
(	NULL
A	NULL
)	NULL
and	NULL
on	NULL
CD8-positive	NULL
or	NULL
-negative	NULL
(	NULL
B	NULL
)	NULL
cells	NULL
within	NULL
a	NULL
given	NULL
transfection	NULL
is	NULL
indicated	NULL
.	NULL

Vector	NULL
plasmids	NULL
were	NULL
pSG5	NULL
(	NULL
A	NULL
)	NULL
and	NULL
CD8	NULL
fused	NULL
to	NULL
the	NULL
immunoglobulin	NULL
alpha	NULL
chain	NULL
(	NULL
B	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Expression	NULL
vectors	NULL
for	NULL
human	NULL
,	NULL
baboon	NULL
,	NULL
and	NULL
rhesus	NULL
LMP1	NULL
in	NULL
pSGS	NULL
;	NULL
(	NULL
B	NULL
)	NULL
CDS	NULL
fusion	NULL
proteins	NULL
with	NULL
the	NULL
complete	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
with	NULL
(	NULL
CD8/B-LMP1	NULL
)	NULL
and	NULL
without	NULL
(	NULL
CD8/B-LMP1AE	NULL
)	NULL
the	NULL
terminal	NULL
13	NULL
aa	NULL
of	NULL
the	NULL
E	NULL
region	NULL
.	NULL

still	NULL
activates	NULL
ICAM1	NULL
expression	NULL
in	NULL
DG75	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
baboon	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
signal	NULL
transduction	NULL
and	NULL
does	NULL
not	NULL
require	NULL
the	NULL
conserved	NULL
LMP1	NULL
transmembrane	NULL
domains	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
well-conserved	NULL
carboxy	NULL
terminus	NULL
(	NULL
baboon	NULL
region	NULL
E	NULL
)	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
CD8-baboon	NULL
LMP1	NULL
fusion	NULL
to	NULL
induce	NULL
ICAM1	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
CD	NULL
&	NULL
8/B-LMP1AE	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
this	NULL
well-conserved	NULL
LMP1	NULL
region	NULL
does	NULL
not	NULL
bind	NULL
TRAF3	NULL
in	NULL
vitro	NULL
and	NULL
is	NULL
not	NULL
essential	NULL
for	NULL
ICAM1	NULL
induction	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
cloned	NULL
and	NULL
analyzed	NULL
the	NULL
EBV	NULL
LMP1	NULL
oncoproteins	NULL
from	NULL
two	NULL
related	NULL
B-lymphotropic	NULL
herpesviruses	NULL
which	NULL
naturally	NULL
infect	NULL
rhesus	NULL
monkeys	NULL
and	NULL
baboons	NULL
.	NULL

The	NULL
LMP1	NULL
sequences	NULL
from	NULL
related	NULL
herpesviruses	NULL
infecting	NULL
two	NULL
Old	NULL
World	NULL
monkeys	NULL
within	NULL
the	NULL
same	NULL
family	NULL
(	NULL
Cercopithidae	NULL
)	NULL
are	NULL
as	NULL
divergent	NULL
from	NULL
each	NULL
other	NULL
as	NULL
they	NULL
are	NULL
from	NULL
human	NULL
EBV	NULL
,	NULL
but	NULL
function	NULL
has	NULL
been	NULL
conserved	NULL
in	NULL
all	NULL
LMP1s	NULL
with	NULL
regard	NULL
to	NULL
inducing	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
,	NULL
binding	NULL
TRAF3	NULL
in	NULL
vitro	NULL
,	NULL
and	NULL
inducing	NULL
the	NULL
TNF	NULL
responsive	NULL
gene	NULL
,	NULL
ICAM1	NULL
.	NULL

Similar	NULL
functional	NULL
conservation	NULL
in	NULL
the	NULL
setting	NULL
of	NULL
global	NULL
sequence	NULL
heterogeneity	NULL
has	NULL
now	NULL
been	NULL
demonstrated	NULL
for	NULL
EBNA-2	NULL
,	NULL
LMP2A	NULL
,	NULL
LMP1	NULL
,	NULL
and	NULL
EBNA-1	NULL
(	NULL
10	NULL
,	NULL
30	NULL
,	NULL
33a	NULL
;	NULL
also	NULL
see	NULL
above	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
protein	NULL
targets	NULL
identified	NULL
to	NULL
date	NULL
for	NULL
these	NULL
viral	NULL
genes	NULL
are	NULL
relatively	NULL
well	NULL
conserved	NULL
and	NULL
can	NULL
not	NULL
explain	NULL
the	NULL
low	NULL
degree	NULL
of	NULL
homology	NULL
for	NULL
latent	NULL
gene	NULL
sequences	NULL
among	NULL
primate	NULL
EBVs	NULL
.	NULL

An	NULL
immunodominant	NULL
T-cell	NULL
epitope	NULL
has	NULL
been	NULL
J.	NULL
ViRoL	NULL
.	NULL

identified	NULL
for	NULL
human	NULL
LMP2A	NULL
but	NULL
lies	NULL
within	NULL
a	NULL
relatively	NULL
well-conserved	NULL
transmembrane	NULL
domain	NULL
so	NULL
that	NULL
immune	NULL
selection	NULL
is	NULL
not	NULL
an	NULL
obvious	NULL
cause	NULL
for	NULL
the	NULL
global	NULL
sequence	NULL
divergence	NULL
(	NULL
10	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Sequence	NULL
diversity	NULL
in	NULL
EBV	NULL
is	NULL
unlikely	NULL
to	NULL
evolve	NULL
rapidly	NULL
,	NULL
since	NULL
EBV	NULL
persistence	NULL
in	NULL
humans	NULL
is	NULL
not	NULL
dependent	NULL
on	NULL
continuous	NULL
replication	NULL
(	NULL
47	NULL
)	NULL
and	NULL
since	NULL
herpesviruses	NULL
replicate	NULL
their	NULL
DNA	NULL
genomes	NULL
with	NULL
relatively	NULL
high	NULL
fidelity	NULL
.	NULL

A	NULL
more	NULL
likely	NULL
explanation	NULL
is	NULL
that	NULL
these	NULL
latent	NULL
,	NULL
transformation-associated	NULL
viral	NULL
genes	NULL
are	NULL
a	NULL
relatively	NULL
recent	NULL
evolutionary	NULL
event	NULL
from	NULL
a	NULL
relatively	NULL
heterogeneous	NULL
gene	NULL
pool	NULL
with	NULL
selection	NULL
for	NULL
specific	NULL
amino	NULL
acid	NULL
residues	NULL
defining	NULL
common	NULL
molecular	NULL
interactions	NULL
with	NULL
conserved	NULL
cell	NULL
proteins	NULL
.	NULL

This	NULL
comparative	NULL
analysis	NULL
of	NULL
naturally	NULL
occurring	NULL
TRAF3-binding	NULL
regions	NULL
in	NULL
the	NULL
human	NULL
,	NULL
baboon	NULL
,	NULL
and	NULL
rhesus	NULL
LMP1	NULL
and	NULL
CD30	NULL
cytoplasmic	NULL
tails	NULL
provides	NULL
an	NULL
initial	NULL
profile	NULL
of	NULL
a	NULL
TRAF3-binding	NULL
motif	NULL
.	NULL

The	NULL
minimal	NULL
TRAF3-binding	NULL
region	NULL
from	NULL
these	NULL
in	NULL
vitro	NULL
studies	NULL
was	NULL
12	NULL
aa	NULL
incorporated	NULL
into	NULL
a	NULL
GST	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
proline	NULL
and	NULL
glutamine	NULL
residues	NULL
of	NULL
the	NULL
core	NULL
sequence	NULL
were	NULL
invariant	NULL
in	NULL
all	NULL
the	NULL
TRAF3-binding	NULL
regions	NULL
studied	NULL
here	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
these	NULL
residues	NULL
is	NULL
confirmed	NULL
by	NULL
the	NULL
marked	NULL
decrease	NULL
in	NULL
binding	NULL
when	NULL
either	NULL
residue	NULL
is	NULL
mutated	NULL
to	NULL
an	NULL
alanine	NULL
.	NULL

Additional	NULL
evidence	NULL
for	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
threonine/serine	NULL
residue	NULL
in	NULL
the	NULL
core	NULL
PXQXT/S	NULL
sequence	NULL
comes	NULL
from	NULL
the	NULL
previous	NULL
observation	NULL
that	NULL
threonine	NULL
234	NULL
of	NULL
CD40	NULL
,	NULL
which	NULL
is	NULL
part	NULL
of	NULL
a	NULL
PXQXT/S	NULL
sequence	NULL
in	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
both	NULL
TRAF3	NULL
binding	NULL
and	NULL
CD40	NULL
signaling	NULL
(	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
threonine	NULL
in	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
of	NULL
the	NULL
rhesus	NULL
region	NULL
C	NULL
in	NULL
our	NULL
studies	NULL
significantly	NULL
reduces	NULL
TRAF3	NULL
binding	NULL
.	NULL

However	NULL
,	NULL
PXQXT/S-containing	NULL
regions	NULL
may	NULL
not	NULL
represent	NULL
the	NULL
only	NULL
TRAF3-binding	NULL
sites	NULL
,	NULL
since	NULL
other	NULL
TRAF3-binding	NULL
receptors	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
the	NULL
p80	NULL
subunit	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
,	NULL
do	NULL
not	NULL
have	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
but	NULL
can	NULL
still	NULL
interact	NULL
with	NULL
TRAF3	NULL
in	NULL
vitro	NULL
(	NULL
34	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
also	NULL
indicate	NULL
that	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
is	NULL
not	NULL
sufficient	NULL
for	NULL
TRAF3	NULL
binding	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
rhesus	NULL
regions	NULL
E	NULL
and	NULL
F	NULL
and	NULL
baboon	NULL
region	NULL
E	NULL
[	NULL
Table	NULL
1	NULL
]	NULL
)	NULL
.	NULL

In	NULL
these	NULL
instances	NULL
,	NULL
this	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
differences	NULL
within	NULL
the	NULL
core	NULL
sequence	NULL
at	NULL
positions	NULL
+1	NULL
and	NULL
+3	NULL
.	NULL

Four	NULL
different	NULL
residues	NULL
are	NULL
tolerated	NULL
at	NULL
position	NULL
+1	NULL
in	NULL
TRAF3-binding	NULL
regions	NULL
from	NULL
LMP1s	NULL
and	NULL
CD30	NULL
,	NULL
but	NULL
only	NULL
glutamic	NULL
acid	NULL
or	NULL
alanine	NULL
residues	NULL
are	NULL
found	NULL
at	NULL
position	NULL
+3	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
also	NULL
likely	NULL
that	NULL
the	NULL
residues	NULL
surrounding	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
and	NULL
the	NULL
three-dimensional	NULL
structure	NULL
of	NULL
the	NULL
core	NULL
sequence	NULL
are	NULL
important	NULL
.	NULL

For	NULL
example	NULL
,	NULL
a	NULL
GST	NULL
protein	NULL
fused	NULL
to	NULL
16	NULL
aa	NULL
from	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
including	NULL
the	NULL
PVQET	NULL
core	NULL
sequence	NULL
fails	NULL
to	NULL
bind	NULL
TRAF3	NULL
in	NULL
vitro	NULL
despite	NULL
the	NULL
reported	NULL
TRAF3-binding	NULL
activity	NULL
of	NULL
the	NULL
entire	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
fused	NULL
to	NULL
GST	NULL
and	NULL
the	NULL
essential	NULL
role	NULL
of	NULL
the	NULL
CD40	NULL
threonine	NULL
234	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
whole	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
9a	NULL
,	NULL
17	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
GST	NULL
protein	NULL
fused	NULL
to	NULL
only	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
within	NULL
a	NULL
12-aa	NULL
alanine	NULL
backbone	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
TRAF3	NULL
in	NULL
vitro	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

TABLE	NULL
2	NULL
.	NULL

Amino	NULL
acid	NULL
residues	NULL
found	NULL
in	NULL
the	NULL
TRAF3-binding	NULL
regions	NULL
from	NULL
CD30	NULL
and	NULL
LMP1	NULL
genes	NULL
Residue	NULL
at	NULL
position	NULL
:	NULL
-500	NULL
0-4	NULL
0-30-20	NULL
-10	NULL
00	NULL
+110	NULL
420	NULL
430	NULL
+40	NULL
450	NULL
+6	NULL
D	NULL
H	NULL
L	NULL
P	NULL
H	NULL
P	NULL
I	NULL
Q	NULL
A	NULL
T	NULL
D	NULL
G	NULL
P	NULL
P	NULL
P	NULL
R	NULL
Y	NULL
V	NULL
E	NULL
S	NULL
G	NULL
D	NULL
Q	NULL
D	NULL
H	NULL
P	NULL
Q	NULL
E	NULL
Y	NULL
H	NULL
N	NULL
T	NULL
E	NULL
P	NULL
S	NULL
T	NULL
VoL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
More	NULL
heterogeneity	NULL
is	NULL
present	NULL
in	NULL
the	NULL
residues	NULL
outside	NULL
of	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
of	NULL
LMP1	NULL
and	NULL
CD30	NULL
TRAF3-binding	NULL
regions	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
.	NULL

The	NULL
residues	NULL
surrounding	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
in	NULL
TRAF3-binding	NULL
regions	NULL
from	NULL
rhesus	NULL
LMP1	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
D	NULL
)	NULL
are	NULL
relatively	NULL
similar	NULL
to	NULL
each	NULL
other	NULL
and	NULL
to	NULL
human	NULL
LMP1	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

However	NULL
,	NULL
residues	NULL
upstream	NULL
of	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
from	NULL
the	NULL
baboon	NULL
TRAF3-binding	NULL
regions	NULL
(	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
are	NULL
quite	NULL
different	NULL
from	NULL
each	NULL
other	NULL
and	NULL
from	NULL
the	NULL
other	NULL
simian	NULL
and	NULL
human	NULL
LMP1	NULL
regions	NULL
.	NULL

The	NULL
CD30	NULL
TRAF3-binding	NULL
region	NULL
introduces	NULL
additional	NULL
heterogeneity	NULL
in	NULL
the	NULL
residues	NULL
surrounding	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
deduce	NULL
a	NULL
common	NULL
motif	NULL
for	NULL
the	NULL
essential	NULL
residues	NULL
outside	NULL
of	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
by	NULL
using	NULL
these	NULL
naturally	NULL
occurring	NULL
TRAF3-binding	NULL
regions	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
human	NULL
LMP1	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
single	NULL
TRAF3-binding	NULL
site	NULL
(	NULL
4b	NULL
)	NULL
whereas	NULL
multiple	NULL
TRAF3-binding	NULL
regions	NULL
are	NULL
repeated	NULL
in	NULL
both	NULL
simian	NULL
LMP1s	NULL
.	NULL

Quantitative	NULL
analysis	NULL
of	NULL
in	NULL
vitro	NULL
TRAF3	NULL
binding	NULL
suggests	NULL
that	NULL
the	NULL
GST	NULL
proteins	NULL
fused	NULL
to	NULL
simian	NULL
LMP1	NULL
cytoplasmic	NULL
domains	NULL
can	NULL
bind	NULL
about	NULL
three	NULL
times	NULL
more	NULL
TRAF3	NULL
than	NULL
can	NULL
human	NULL
LMP1	NULL
when	NULL
assayed	NULL
on	NULL
an	NULL
equimolar	NULL
basis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
multiple	NULL
TRAF3-binding	NULL
sites	NULL
in	NULL
simian	NULL
LMP1s	NULL
either	NULL
bind	NULL
multiple	NULL
TRAF3	NULL
molecules	NULL
or	NULL
act	NULL
in	NULL
concert	NULL
to	NULL
enhance	NULL
the	NULL
affinity	NULL
of	NULL
TRAF3	NULL
binding	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
partial	NULL
baboon	NULL
LMP1	NULL
cDNA	NULL
to	NULL
induce	NULL
ICAM1	NULL
and	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
and	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
CD8-baboon	NULL
LMP1	NULL
fusion	NULL
to	NULL
induce	NULL
ICAMI1	NULL
expression	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
multiple	NULL
TRAF3-binding	NULL
sites	NULL
might	NULL
be	NULL
functionally	NULL
relevant	NULL
,	NULL
since	NULL
it	NULL
is	NULL
predicted	NULL
that	NULL
these	NULL
mutant	NULL
LMP1	NULL
proteins	NULL
would	NULL
not	NULL
patch	NULL
in	NULL
the	NULL
cell	NULL
membrane	NULL
.	NULL

Thus	NULL
,	NULL
different	NULL
mechanisms	NULL
can	NULL
contribute	NULL
to	NULL
TRAF3	NULL
clustering	NULL
and	NULL
signalling	NULL
through	NULL
the	NULL
TNF	NULL
receptor	NULL
pathway	NULL
:	NULL
cross-linking	NULL
of	NULL
receptor	NULL
and	NULL
ligand	NULL
,	NULL
such	NULL
as	NULL
CD40	NULL
with	NULL
CD4O0L	NULL
(	NULL
30	NULL
)	NULL
;	NULL
constitutive	NULL
aggregation/patching	NULL
of	NULL
a	NULL
TRAF3	NULL
binding	NULL
protein	NULL
,	NULL
such	NULL
as	NULL
LMP1	NULL
(	NULL
27	NULL
,	NULL
41	NULL
)	NULL
;	NULL
and	NULL
multiple	NULL
TRAF3	NULL
binding	NULL
sites	NULL
within	NULL
a	NULL
single	NULL
cytoplasmic	NULL
domain	NULL
,	NULL
as	NULL
in	NULL
the	NULL
simian	NULL
LMP1s	NULL
.	NULL

Recent	NULL
genetic	NULL
and	NULL
functional	NULL
studies	NULL
have	NULL
increasingly	NULL
focused	NULL
on	NULL
the	NULL
LMP1	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
and	NULL
on	NULL
differences	NULL
between	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domains	NULL
.	NULL

Recombinant	NULL
EBV	NULL
containing	NULL
an	NULL
LMP1	NULL
truncated	NULL
at	NULL
aa	NULL
231	NULL
can	NULL
still	NULL
immortalize	NULL
B	NULL
cells	NULL
when	NULL
a	NULL
feeder	NULL
cell	NULL
layer	NULL
is	NULL
provided	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
proximal	NULL
44	NULL
aa	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
LMP1	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
sufficient	NULL
for	NULL
B-cell	NULL
growth	NULL
transformation	NULL
but	NULL
suggesting	NULL
that	NULL
the	NULL
distal	NULL
sequences	NULL
also	NULL
provide	NULL
a	NULL
growth	NULL
factor-like	NULL
effect	NULL
(	NULL
23	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

(	NULL
34	NULL
)	NULL
,	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

(	NULL
4a	NULL
)	NULL
,	NULL
and	NULL
the	NULL
present	NULL
study	NULL
suggest	NULL
that	NULL
the	NULL
critical	NULL
region	NULL
within	NULL
those	NULL
proximal	NULL
44	NULL
aa	NULL
is	NULL
a	NULL
TRAF3-binding	NULL
domain	NULL
containing	NULL
a	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
.	NULL

Indeed	NULL
,	NULL
the	NULL
protein	NULL
sequence	NULL
of	NULL
this	NULL
proximal	NULL
human	NULL
LMP1	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
is	NULL
invariant	NULL
from	NULL
all	NULL
human	NULL
EBV	NULL
isolates	NULL
sequenced	NULL
to	NULL
date	NULL
,	NULL
whereas	NULL
the	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
in	NULL
human	NULL
LMP1	NULL
region	NULL
B	NULL
is	NULL
frequently	NULL
disrupted	NULL
by	NULL
strain	NULL
variation	NULL
(	NULL
32	NULL
,	NULL
42	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
indicate	NULL
that	NULL
the	NULL
majority	NULL
of	NULL
NF-	NULL
Â«	NULL
B-inducing	NULL
activity	NULL
resides	NULL
in	NULL
the	NULL
more	NULL
distal	NULL
portions	NULL
of	NULL
LMP1	NULL
,	NULL
specifically	NULL
the	NULL
last	NULL
55	NULL
aa	NULL
,	NULL
despite	NULL
the	NULL
essential	NULL
role	NULL
for	NULL
the	NULL
proximal	NULL
44	NULL
aa	NULL
of	NULL
the	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
(	NULL
18	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Our	NULL
studies	NULL
demonstrate	NULL
that	NULL
human	NULL
and	NULL
simian	NULL
LMP1s	NULL
induce	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
to	NULL
comparable	NULL
levels	NULL
in	NULL
human	NULL
fibroblasts	NULL
and	NULL
that	NULL
the	NULL
most	NULL
homologous	NULL
region	NULL
within	NULL
the	NULL
last	NULL
55	NULL
aa	NULL
lies	NULL
within	NULL
the	NULL
terminal	NULL
PXQXT/S	NULL
core	NULL
sequence	NULL
followed	NULL
by	NULL
a	NULL
tyrosine	NULL
re-peat	NULL
.	NULL

This	NULL
region	NULL
fails	NULL
to	NULL
bind	NULL
TRAF3	NULL
in	NULL
vitro	NULL
(	NULL
in	NULL
human	NULL
EBV	NULL
[	NULL
4a	NULL
]	NULL
and	NULL
simian	NULL
EBV	NULL
[	NULL
see	NULL
abovel	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
well-conserved	NULL
terminal	NULL
region	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
inducing	NULL
NF-	NULL
Â«	NULL
B	NULL
activity	NULL
by	NULL
a	NULL
TRAF3-independent	NULL
mechanism	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
that	NULL
the	NULL
simian	NULL
LMP1s	NULL
are	NULL
not	NULL
associated	NULL
with	NULL
the	NULL
marked	NULL
cell	NULL
toxicity	NULL
typically	NULL
demonstrated	NULL
by	NULL
human	NULL
TRAF3	NULL
BINDING	NULL
SITES	NULL
IN	NULL
EBV	NULL
LMPI	NULL
7825	NULL
LMP1	NULL
expression	NULL
,	NULL
despite	NULL
comparable	NULL
or	NULL
better	NULL
TRAF3	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

Human	NULL
LMP1	NULL
cell	NULL
toxicity	NULL
is	NULL
frequently	NULL
demonstrated	NULL
by	NULL
the	NULL
difficulties	NULL
associated	NULL
with	NULL
transient	NULL
and	NULL
stable	NULL
LMP1	NULL
transfection	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
LMP1-induced	NULL
cell	NULL
toxicity	NULL
can	NULL
be	NULL
minimized	NULL
by	NULL
modifying	NULL
transfection	NULL
techniques	NULL
,	NULL
the	NULL
simian	NULL
LMP1s	NULL
have	NULL
different	NULL
effects	NULL
on	NULL
cell	NULL
survival	NULL
from	NULL
that	NULL
of	NULL
human	NULL
LMP1	NULL
under	NULL
identical	NULL
transfection	NULL
conditions	NULL
in	NULL
these	NULL
experiments	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
cell	NULL
toxicity	NULL
after	NULL
LMP1	NULL
transfection	NULL
has	NULL
made	NULL
it	NULL
difficult	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
induction	NULL
of	NULL
anti-apoptotic	NULL
genes	NULL
be/-2	NULL
and	NULL
A20	NULL
associated	NULL
with	NULL
stable	NULL
LMP1	NULL
transfection	NULL
are	NULL
due	NULL
to	NULL
direct	NULL
stimulation	NULL
by	NULL
LMP1	NULL
or	NULL
a	NULL
cell	NULL
response	NULL
to	NULL
LMP1	NULL
cytotoxic	NULL
effects	NULL
(	NULL
15	NULL
,	NULL
24	NULL
,	NULL
31	NULL
,	NULL
41	NULL
)	NULL
.	NULL

It	NULL
will	NULL
be	NULL
interesting	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
less	NULL
toxic	NULL
simian	NULL
LMP1s	NULL
are	NULL
still	NULL
capable	NULL
of	NULL
inducing	NULL
be/-2	NULL
and	NULL
A20	NULL
.	NULL

Whether	NULL
the	NULL
lack	NULL
of	NULL
cytotoxicity	NULL
with	NULL
simian	NULL
LMP1	NULL
is	NULL
due	NULL
to	NULL
differences	NULL
in	NULL
TRAF3-binding	NULL
affinity	NULL
intracellularly	NULL
or	NULL
to	NULL
an	NULL
unrelated	NULL
mechanism	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Conservation	NULL
of	NULL
a	NULL
common	NULL
TRAF3-binding	NULL
site	NULL
in	NULL
CD30	NULL
and	NULL
the	NULL
simian	NULL
and	NULL
human	NULL
LMP1s	NULL
provides	NULL
compelling	NULL
evidence	NULL
that	NULL
a	NULL
TRAF3-dependent	NULL
signalling	NULL
pathway	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
malignant	NULL
transformation	NULL
associated	NULL
with	NULL
these	NULL
genes	NULL
.	NULL

CD30	NULL
and	NULL
LMP1	NULL
expression	NULL
is	NULL
closely	NULL
associated	NULL
with	NULL
the	NULL
Reed-Sternberg	NULL
cells	NULL
in	NULL
Hodgkin	NULL
's	NULL
disease	NULL
.	NULL

CD30	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
which	NULL
was	NULL
originally	NULL
discovered	NULL
as	NULL
a	NULL
Hodgkin	NULL
's	NULL
disease	NULL
marker	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
on	NULL
Reed-Sternberg	NULL
cells	NULL
(	NULL
6	NULL
)	NULL
.	NULL

There	NULL
is	NULL
increasing	NULL
evidence	NULL
for	NULL
a	NULL
causal	NULL
association	NULL
of	NULL
EBV	NULL
in	NULL
certain	NULL
types	NULL
of	NULL
Hodgkin	NULL
's	NULL
disease	NULL
,	NULL
and	NULL
LMP1	NULL
is	NULL
commonly	NULL
expressed	NULL
in	NULL
Reed-Sternberg	NULL
cells	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
LMP1	NULL
expression	NULL
is	NULL
common	NULL
in	NULL
other	NULL
human	NULL
malignancies	NULL
,	NULL
including	NULL
EBV-infected	NULL
B-cell	NULL
lymphomas	NULL
and	NULL
nasopharyngeal	NULL
carcinomas	NULL
,	NULL
and	NULL
LMP1	NULL
is	NULL
the	NULL
only	NULL
EBV	NULL
latent	NULL
gene	NULL
which	NULL
demonstrates	NULL
oncogene	NULL
properties	NULL
in	NULL
rodent	NULL
fibroblast	NULL
assays	NULL
(	NULL
36	NULL
,	NULL
43	NULL
,	NULL
48	NULL
)	NULL
.	NULL

Simian	NULL
EBVs	NULL
are	NULL
frequently	NULL
found	NULL
in	NULL
B-cell	NULL
lymphomas	NULL
arising	NULL
in	NULL
monkeys	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus-induced	NULL
immunodeficiency	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
B-cell	NULL
lymphomas	NULL
occurring	NULL
in	NULL
AIDS	NULL
patients	NULL
(	NULL
8	NULL
,	NULL
26	NULL
)	NULL
.	NULL

The	NULL
diversity	NULL
of	NULL
peptide	NULL
sequences	NULL
associated	NULL
with	NULL
these	NULL
TRAF3-binding	NULL
sites	NULL
and	NULL
the	NULL
possibility	NULL
of	NULL
other	NULL
,	NULL
non-PXQXT/	NULL
S-containing	NULL
TRAF3-binding	NULL
sites	NULL
suggest	NULL
that	NULL
it	NULL
may	NULL
be	NULL
possible	NULL
to	NULL
target	NULL
the	NULL
TRAF3	NULL
interaction	NULL
to	NULL
this	NULL
viral	NULL
oncogene	NULL
with	NULL
some	NULL
level	NULL
of	NULL
specificity	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
USPHS	NULL
grants	NULL
CA68051	NULL
and	NULL
CA65319	NULL
.	NULL

MR.	NULL
and	NULL
the	NULL
FACS	NULL
facilities	NULL
were	NULL
supported	NULL
by	NULL
PHS	NULL
P51RR00168-34	NULL
.	NULL

MF	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Dr.	NULL
Mildred-Scheel	NULL
Stiftung	NULL
fiir	NULL
Krebsforschung	NULL
.	NULL

We	NULL
thank	NULL
George	NULL
Mosialos	NULL
,	NULL
Amir	NULL
Moghaddam	NULL
and	NULL
Paul	NULL
Johnson	NULL
for	NULL
valuable	NULL
advice	NULL
and	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ablashi	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
P.	NULL
Gerber	NULL
,	NULL
and	NULL
J.	NULL
Easton	NULL
.	NULL

1979	NULL
.	NULL

Oncogenic	NULL
herpesviruses	NULL
of	NULL
nonhuman	NULL
primates	NULL
.	NULL

Comp	NULL
.	NULL

Immunol	NULL
.	NULL

Microbiol	NULL
.	NULL

Infect	NULL
.	NULL

Dis	NULL
.	NULL

2:229-241	NULL
.	NULL

2	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
Bazan	NULL
,	NULL
D.	NULL
Blanchard	NULL
,	NULL
F.	NULL
Briere	NULL
,	NULL
J.	NULL
P.	NULL
Galizzi	NULL
,	NULL
C.	NULL
van	NULL
Kooten	NULL
,	NULL
Y.	NULL
J.	NULL
Liu	NULL
,	NULL
F.	NULL
Rousset	NULL
,	NULL
and	NULL
S.	NULL
Saeland	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
CD40	NULL
antigen	NULL
and	NULL
its	NULL
ligand	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

12:881-922	NULL
.	NULL

3	NULL
.	NULL

Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
J	NULL
.	NULL

Sample	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
increases	NULL
vimentin	NULL
expression	NULL
in	NULL
human	NULL
B-cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:4079-4084	NULL
.	NULL

4	NULL
.	NULL

Cheng	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
M.	NULL
Cleary	NULL
,	NULL
Z.	NULL
S.	NULL
Ye	NULL
,	NULL
D.	NULL
I.	NULL
Hong	NULL
,	NULL
S.	NULL
Lederman	NULL
,	NULL
and	NULL
D.	NULL
Balti-more	NULL
.	NULL

1995	NULL
.	NULL

Involvement	NULL
of	NULL
CRAF1	NULL
,	NULL
a	NULL
relative	NULL
of	NULL
TRAF	NULL
,	NULL
in	NULL
CD40	NULL
signaling	NULL
.	NULL

Science	NULL
267:1494-1498	NULL
.	NULL

4a.Devergne	NULL
,	NULL
O.	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

5	NULL
.	NULL

Dunkel	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
T.	NULL
W.	NULL
Pry	NULL
,	NULL
G.	NULL
Henle	NULL
,	NULL
and	NULL
W.	NULL
Henle	NULL
.	NULL

1972	NULL
.	NULL

Immunofluorescence	NULL
tests	NULL
for	NULL
antibodies	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
with	NULL
sera	NULL
of	NULL
lower	NULL
primates	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

49:435-440	NULL
.	NULL

6	NULL
.	NULL

Falini	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
Pileri	NULL
,	NULL
G.	NULL
Pizzolo	NULL
,	NULL
H.	NULL
Durkop	NULL
,	NULL
L.	NULL
Flenghi	NULL
,	NULL
F.	NULL
Stirpe	NULL
,	NULL
M.	NULL
F.	NULL
Martelli	NULL
,	NULL
and	NULL
H.	NULL
Stein	NULL
.	NULL

1995	NULL
.	NULL

CD30	NULL
(	NULL
Ki-1	NULL
)	NULL
molecule	NULL
:	NULL
a	NULL
new	NULL
cytokine	NULL
receptor	NULL
7826	NULL
FRANKEN	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
superfamily	NULL
as	NULL
a	NULL
tool	NULL
for	NULL
diagnosis	NULL
and	NULL
immunotherapy	NULL
.	NULL

Blood	NULL
85:1-14.	NULL
.	NULL

Falk	NULL
,	NULL
L.	NULL
,	NULL
F.	NULL
Deinhardt	NULL
,	NULL
M.	NULL
Nonoyama	NULL
,	NULL
L.	NULL
G.	NULL
Wolfe	NULL
,	NULL
and	NULL
C.	NULL
Bergholz	NULL
.	NULL

1976	NULL
.	NULL

Properties	NULL
of	NULL
a	NULL
baboon	NULL
lymphotropic	NULL
herpesvirus	NULL
related	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
18:798-807.	NULL
.	NULL

Feichtinger	NULL
,	NULL
H.	NULL
,	NULL
P.	NULL
Putkonen	NULL
,	NULL
C.	NULL
Parravicini	NULL
,	NULL
S.	NULL
T.	NULL
Li	NULL
,	NULL
E.	NULL
E.	NULL
Kaya	NULL
,	NULL
D.	NULL
Bottiger	NULL
,	NULL
and	NULL
P.	NULL
Biberfeld	NULL
.	NULL

1990	NULL
.	NULL

Malignant	NULL
lymphomas	NULL
in	NULL
cynomolgus	NULL
monkeys	NULL
infected	NULL
with	NULL
simian	NULL
immunodeficiency	NULL
virus	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

137:1311-1315.	NULL
.	NULL

Frank	NULL
,	NULL
A.	NULL
,	NULL
W.	NULL
A.	NULL
Andiman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
,	NULL
1976	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
and	NULL
nonhuman	NULL
primates	NULL
:	NULL
natural	NULL
and	NULL
experimental	NULL
infection	NULL
.	NULL

Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

23:171-201	NULL
.	NULL

9a.Franken	NULL
,	NULL
M.	NULL
Unpublished	NULL
data	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

Franken	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
Annis	NULL
,	NULL
A.	NULL
Ali	NULL
,	NULL
and	NULL
F.	NULL
Wang	NULL
.	NULL

1995	NULL
.	NULL

5	NULL
'	NULL
coding	NULL
and	NULL
regulatory	NULL
region	NULL
sequence	NULL
divergence	NULL
with	NULL
conserved	NULL
function	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
LMP2A	NULL
homolog	NULL
in	NULL
herpesvirus	NULL
papio	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:8011-8019	NULL
.	NULL

Gerber	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
S.	NULL
Kalter	NULL
,	NULL
G.	NULL
Schidlovsky	NULL
,	NULL
W.	NULL
J.	NULL
Peterson	NULL
,	NULL
and	NULL
M.	NULL
D.	NULL
Daniel	NULL
.	NULL

1977	NULL
.	NULL

Biologic	NULL
and	NULL
antigenic	NULL
characteristics	NULL
of	NULL
Epstein-Barr	NULL
virus-related	NULL
herpesviruses	NULL
of	NULL
chimpanzees	NULL
and	NULL
baboons	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
20:448-459	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.	NULL
L.	NULL
,	NULL
and	NULL
M.	NULL
C.	NULL
Simurda	NULL
.	NULL

1992	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
through	NULL
induction	NULL
of	NULL
NF-kappa	NULL
B	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:6496-6501	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
,	NULL
B.	NULL
Sugden	NULL
,	NULL
and	NULL
V.	NULL
R.	NULL
Baichwal	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
transforming	NULL
domain	NULL
alone	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
is	NULL
toxic	NULL
to	NULL
cells	NULL
when	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:2469-2475	NULL
.	NULL

Heller	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Gerber	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1981	NULL
.	NULL

Herpesvirus	NULL
papio	NULL
DNA	NULL
is	NULL
similar	NULL
in	NULL
organization	NULL
to	NULL
Epstein-Barr	NULL
virus	NULL
DNA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

37:698-709	NULL
.	NULL

Henderson	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
R.	NULL
Long-necker	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A.	NULL
Rickinson	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
bel-2	NULL
expression	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
protects	NULL
infected	NULL
B	NULL
cells	NULL
from	NULL
programmed	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
65:1107-1115	NULL
.	NULL

Herbst	NULL
,	NULL
H.	NULL
,	NULL
F.	NULL
Dallenbach	NULL
,	NULL
M.	NULL
H	NULL
1	NULL
,	NULL
G.	NULL
Niedobitek	NULL
,	NULL
S.	NULL
Pileri	NULL
,	NULL
N.	NULL
Muller-Lantzsch	NULL
,	NULL
and	NULL
H.	NULL
Stein	NULL
.	NULL

1991	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
expression	NULL
in	NULL
Hodgkin	NULL
and	NULL
Reed-Sternberg	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
88:4766-4770	NULL
.	NULL

Hu	NULL
,	NULL
H.	NULL
M.	NULL
,	NULL
K.	NULL
O'Rourke	NULL
,	NULL
M.	NULL
S.	NULL
Boguski	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
RING	NULL
finger	NULL
protein	NULL
interacts	NULL
with	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
CD40	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30069-30072	NULL
.	NULL

Huen	NULL
,	NULL
D.	NULL
S.	NULL
,	NULL
S.	NULL
A.	NULL
Henderson	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
and	NULL
M.	NULL
Rowe	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
mediates	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
via	NULL
two	NULL
effector	NULL
regions	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Oncogene	NULL
10:549-560	NULL
.	NULL

Inui	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Kaisho	NULL
,	NULL
H.	NULL
Kikutani	NULL
,	NULL
I	NULL
Stamenkovic	NULL
,	NULL
B	NULL
.	NULL

Seed	NULL
,	NULL
E.	NULL
A.	NULL
Clark	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
intracytoplasmic	NULL
region	NULL
essential	NULL
for	NULL
signal	NULL
transduction	NULL
through	NULL
a	NULL
B	NULL
cell	NULL
activation	NULL
molecule	NULL
,	NULL
CD40	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

20:1747-1753	NULL
.	NULL

Irving	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
A.	NULL
Weiss	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
zeta	NULL
chain	NULL
is	NULL
sufficient	NULL
to	NULL
couple	NULL
to	NULL
receptor-associated	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
64:891-901	NULL
.	NULL

Kalter	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
R.	NULL
L.	NULL
Heberling	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Ratner	NULL
.	NULL

1972	NULL
.	NULL

EBV	NULL
antibody	NULL
in	NULL
sera	NULL
of	NULL
nonhuman	NULL
primates	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
238:353-354	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:9150-9154	NULL
.	NULL

Kaye	NULL
,	NULL
K.	NULL
M.	NULL
,	NULL
K.	NULL
M.	NULL
Izumi	NULL
,	NULL
G.	NULL
Mosialos	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
cytoplasmic	NULL
carboxy	NULL
terminus	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
:	NULL
fibroblast	NULL
cocultivation	NULL
complements	NULL
a	NULL
critical	NULL
function	NULL
within	NULL
the	NULL
terminal	NULL
155	NULL
residues	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:675-683	NULL
.	NULL

Laherty	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
H.	NULL
M.	NULL
Hu	NULL
,	NULL
A.	NULL
W.	NULL
Opipari	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
V.	NULL
M.	NULL
Dixit	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
kappa	NULL
B.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:24157-24160.	NULL
.	NULL

Landon	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
L.	NULL
B.	NULL
Ellis	NULL
,	NULL
V.	NULL
H.	NULL
Zeve	NULL
,	NULL
and	NULL
D.	NULL
P.	NULL
Fabrizio	NULL
.	NULL

1968	NULL
.	NULL

Herpes-type	NULL
virus	NULL
in	NULL
cultured	NULL
leukocytes	NULL
from	NULL
chimpanzees	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

40:181-192	NULL
.	NULL

Lapin	NULL
,	NULL
B	NULL
.	NULL

A	NULL
.	NULL

1974	NULL
.	NULL

The	NULL
epidemiologic	NULL
and	NULL
genetic	NULL
aspect	NULL
of	NULL
an	NULL
outbreak	NULL
of	NULL
leukemia	NULL
among	NULL
baboons	NULL
of	NULL
the	NULL
Sukhumi	NULL
monkey	NULL
colony	NULL
in	NULL
Dutcher	NULL
and	NULL
Chieco-Bianchi	NULL
.	NULL

Unifying	NULL
concepts	NULL
of	NULL
leukemia	NULL
.	NULL

Bibl	NULL
.	NULL

Haematol	NULL
.	NULL

39:263-268	NULL
.	NULL

Lee	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
W.	NULL
A.	NULL
Thomas	NULL
,	NULL
R.	NULL
J.	NULL
Murray	NULL
,	NULL
F.	NULL
Khanim	NULL
,	NULL
S.	NULL
Kaur	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
M.	NULL
Kurilla	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1993	NULL
.	NULL

HLA	NULL
AZ2.1-restricted	NULL
cytotoxic	NULL
T	NULL
cells	NULL
recognizing	NULL
a	NULL
range	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
isolates	NULL
through	NULL
a	NULL
defined	NULL
epitope	NULL
in	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:7428-7435	NULL
.	NULL

Liebowitz	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
Mannick	NULL
,	NULL
K.	NULL
Takada	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1992	NULL
.	NULL

Phenotypes	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
deletion	NULL
mutants	NULL
indicate	NULL
transmembrane	NULL
and	NULL
amino-terminal	NULL
cytoplasmic	NULL
domains	NULL
necessary	NULL
for	NULL
effects	NULL
in	NULL
B-lymphoma	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:4612-4616	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

J.	NULL
ViRoL	NULL
.	NULL

Ling	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1995	NULL
.	NULL

Contribution	NULL
of	NULL
conserved	NULL
amino	NULL
acids	NULL
in	NULL
mediating	NULL
the	NULL
interaction	NULL
between	NULL
EBNAZ	NULL
and	NULL
CBF1/RBPJk	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1944-1950	NULL
.	NULL

Ling	NULL
,	NULL
P.	NULL
D.	NULL
,	NULL
J.	NULL
J.	NULL
Ryon	NULL
,	NULL
and	NULL
S.	NULL
D.	NULL
Hayward	NULL
.	NULL

1993	NULL
.	NULL

EBNA-2	NULL
of	NULL
herpesvirus	NULL
papio	NULL
diverges	NULL
significantly	NULL
from	NULL
the	NULL
type	NULL
A	NULL
and	NULL
type	NULL
B	NULL
EBNA-2	NULL
proteins	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
but	NULL
retains	NULL
an	NULL
efficient	NULL
transactivation	NULL
domain	NULL
with	NULL
a	NULL
conserved	NULL
hydrophobic	NULL
motif	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2990-3003	NULL
.	NULL

Martin	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
D.	NULL
Veis	NULL
,	NULL
S.	NULL
J.	NULL
Korsmeyer	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1993	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
induces	NULL
cellular	NULL
phenotypes	NULL
independently	NULL
of	NULL
expression	NULL
of	NULL
Bel-2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:5269-5278	NULL
.	NULL

Miller	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
R.	NULL
H.	NULL
Edwards	NULL
,	NULL
D.	NULL
M.	NULL
Walling	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1994	NULL
.	NULL

Sequence	NULL
variation	NULL
in	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

75:2729-2740	NULL
.	NULL

Mitchell	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
B.	NULL
Sugden	NULL
.	NULL

1995	NULL
.	NULL

Stimulation	NULL
of	NULL
NF-kappa	NULL
B-mediated	NULL
transcription	NULL
by	NULL
mutant	NULL
derivatives	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:2968-2976	NULL
.	NULL

33a	NULL
.	NULL

Moghaddam	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
F.	NULL
Wang	NULL
.	NULL

Unpublished	NULL
observations	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389-399	NULL
.	NULL

Myers	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
S.	NULL
J.	NULL
Wertheimer	NULL
,	NULL
J.	NULL
Schembri-King	NULL
,	NULL
T.	NULL
Parks	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Wallace	NULL
.	NULL

1992	NULL
.	NULL

Induction	NULL
of	NULL
ICAM-1	NULL
by	NULL
TNF-alpha	NULL
,	NULL
IL-1	NULL
beta	NULL
,	NULL
and	NULL
LPS	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
after	NULL
downregulation	NULL
of	NULL
PKC	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Physiol	NULL
.	NULL

263	NULL
:	NULL
C767-C772	NULL
.	NULL

Pathmanathan	NULL
,	NULL
R.	NULL
,	NULL
U.	NULL
Prasad	NULL
,	NULL
R.	NULL
Sadler	NULL
,	NULL
K.	NULL
Flynn	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1995	NULL
.	NULL

Clonal	NULL
proliferations	NULL
of	NULL
cells	NULL
infected	NULL
with	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
pre-invasive	NULL
lesions	NULL
related	NULL
to	NULL
nasopharyngeal	NULL
carcinoma	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

333	NULL
:	NULL
693-698	NULL
.	NULL

Peng	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
E.	NULL
Lundgren	NULL
.	NULL

1992	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
in	NULL
human	NULL
primary	NULL
B	NULL
cells	NULL
induces	NULL
cellular	NULL
activation	NULL
and	NULL
DNA	NULL
synthesis	NULL
.	NULL

Oncogene	NULL
7:1775-1782	NULL
.	NULL

Rabin	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
H.	NULL
Neubauer	NULL
,	NULL
R.	NULL
F.	NULL
D.	NULL
Hopkins	NULL
,	NULL
and	NULL
M.	NULL
Nonoyama	NULL
.	NULL

1978	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
a	NULL
herpesvirus-positive	NULL
orang-utan	NULL
cell	NULL
line	NULL
and	NULL
comparative	NULL
aspects	NULL
of	NULL
in	NULL
vitro	NULL
transformation	NULL
with	NULL
lymphotropic	NULL
old	NULL
world	NULL
primate	NULL
herpesviruses	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
21:762-767	NULL
.	NULL

Rangan	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
L.	NULL
N.	NULL
Martin	NULL
,	NULL
B.	NULL
E.	NULL
Bozelka	NULL
,	NULL
N.	NULL
Wang	NULL
,	NULL
and	NULL
B.	NULL
J.	NULL
Gormus	NULL
.	NULL

1986	NULL
.	NULL

Epstein-Barr	NULL
virus-related	NULL
herpesvirus	NULL
from	NULL
a	NULL
rhesus	NULL
monkey	NULL
(	NULL
Macaca	NULL
mulatta	NULL
)	NULL
with	NULL
malignant	NULL
lymphoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
38:425-432	NULL
.	NULL

Rickinson	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1996	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
,	NULL
p.	NULL
2397-2446	NULL
.	NULL

In	NULL
D.	NULL
Knipe	NULL
,	NULL
B	NULL
.	NULL

Fields	NULL
,	NULL
and	NULL
P.	NULL
Howley	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Fields	NULL
virology	NULL
.	NULL

Raven	NULL
Press	NULL
,	NULL
Phila-delphia	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Peng-Pilon	NULL
,	NULL
D.	NULL
S.	NULL
Huen	NULL
,	NULL
R.	NULL
Hardy	NULL
,	NULL
D.	NULL
Croom-Carter	NULL
,	NULL
E.	NULL
Lundgren	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1994	NULL
.	NULL

Upregulation	NULL
of	NULL
bel-2	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP1	NULL
:	NULL
a	NULL
B-cell-specific	NULL
response	NULL
that	NULL
is	NULL
delayed	NULL
relative	NULL
to	NULL
NF-kappa	NULL
B	NULL
activation	NULL
and	NULL
to	NULL
induction	NULL
of	NULL
cell	NULL
surface	NULL
markers	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:5602-5612	NULL
.	NULL

Sample	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Kieff	NULL
,	NULL
and	NULL
E.	NULL
D.	NULL
Kieff	NULL
.	NULL

1994	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
types	NULL
1	NULL
and	NULL
2	NULL
have	NULL
nearly	NULL
identical	NULL
LMP-1	NULL
transforming	NULL
genes	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

75:2741-2746	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1985	NULL
.	NULL

An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
43:831-840	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gregory	NULL
,	NULL
C.	NULL
Sample	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
D.	NULL
Liebowitz	NULL
,	NULL
R.	NULL
Murray	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2309-2318	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
S.	NULL
F.	NULL
Tsang	NULL
,	NULL
M.	NULL
G.	NULL
Kurilla	NULL
,	NULL
J.	NULL
L	NULL
Cohen	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
2	NULL
transactivates	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:3407-3416	NULL
.	NULL

Wertheimer	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
C.	NULL
L.	NULL
Myers	NULL
,	NULL
R.	NULL
W.	NULL
Wallace	NULL
,	NULL
and	NULL
T.	NULL
P.	NULL
Parks	NULL
.	NULL

1992	NULL
.	NULL

Intercellular	NULL
adhesion	NULL
molecule-1	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
endothelial	NULL
cells	NULL
.	NULL

Differential	NULL
regulation	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-alpha	NULL
and	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:12030-12035.	NULL
.	NULL

Yao	NULL
,	NULL
Q.	NULL
Y.	NULL
,	NULL
P.	NULL
Ogan	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1989	NULL
.	NULL

Epstein	NULL
Barr	NULL
virus-infected	NULL
B	NULL
cells	NULL
persist	NULL
in	NULL
the	NULL
circulation	NULL
of	NULL
acyclovir-treated	NULL
virus	NULL
carriers	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
43:67-71.	NULL
.	NULL

Young	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Alfieri	NULL
,	NULL
K.	NULL
Hennessy	NULL
,	NULL
H.	NULL
Evans	NULL
,	NULL
C.	NULL
O'Hara	NULL
,	NULL
K.	NULL
C.	NULL
Anderson	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
R.	NULL
S.	NULL
Shapiro	NULL
,	NULL
A.	NULL
Rickinson	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
transformation-associated	NULL
genes	NULL
in	NULL
tissues	NULL
of	NULL
patients	NULL
with	NULL
EBV	NULL
lymphoproliferative	NULL
disease	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

321:1080-1085.	NULL
.	NULL

Zhang	NULL
,	NULL
Q.	NULL
,	NULL
L.	NULL
Brooks	NULL
,	NULL
P.	NULL
Busson	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
D.	NULL
Charron	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
,	NULL
and	NULL
T.	NULL
Tursz	NULL
.	NULL

1994	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
increases	NULL
HLA	NULL
class	NULL
II	NULL
expression	NULL
in	NULL
an	NULL
EBV-negative	NULL
B	NULL
cell	NULL
line	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:1467-1470	NULL
.	NULL

